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ABSTRACT OF DISSERTATION 
ENTRY AND EARLY INFECTION OF NON-SEGMENTED NEGATIVE SENSE 
RNA VIRUSES 
Paramyxoviruses, pneumoviruses, and other non-segmented negative 
sense (NNS) RNA viruses have historically been of public health concern. 
Although their genomes are typically small (up to 19kbs) they are able to inflict 
large-scale detrimental pathologies on host cells. Human metapneumovirus 
(HMPV) is a widespread pathogen and is a NNS RNA virus. HMPV results 
respiratory tract infections and  is particularly dangerous for preterm infants, the 
elderly, and immunocompromised individuals. Other viruses within the NNS 
RNA virus order include the deadly Ebola, Hendra, and Nipah viruses (EBOV, 
HeV, and NiV), as well as the re-emerging measles virus (MeV). Despite their 
public impact, there are currently very limited available FDA-approved 
therapeutics and antivirals against NNS RNA viruses. 
During the infectious cycle, viral surface glycoproteins play critical roles 
in establishing infection. For most NNS RNA viruses, the attachment protein is 
important for the tethering of a viral membrane to host cells, while the fusion 
protein is responsible for the membrane merger of the virus and host. The fusion 
protein of paramyxo-and pneumovirus proteins are class I proteins that are 
folded into trimers, must be proteolytically cleaved to be functional, and are held 
in a metastable prefusion conformation until the signal for fusion occurs. Upon 
being signaled, the fusion protein undergoes dramatic essentially irreversible 
conformational changes for membrane mixing. Because of its important role in 
starting infection, F has garnered interest as a potentially powerful target against 
infection. For paramyxoviruses, the ectodomain regions of F have been well-
studied; however, the hydrophobic nature of the transmembrane domain (TMD) 
of the protein has resulted in difficulties in crystallization. To address this, 
several biochemical assays have been utilized to address the function of the 
TMDs of paramyxo-and pneumovirus fusion proteins. Although initially thought 
to be solely a membrane anchor, the transmembrane domains of several 
viruses have been shown to be important for the functionality of fusion proteins. 
For some paramyxoviruses, replacement of the proteinaceous TMD resulted in 
the premature triggering. Further studies showed that the TMDs of 
paramyxoviruses and several other viral F proteins exist in isolation as trimers, 
and these trimeric associations in turn drive trimeric associations of the full 
protein. Studies of the HeV F TMD in isolation identified a leucine/isoleucine 
(L/I) zipper as an important motif for TMD-TMD trimerization. Mutations to this 
L/I zipper motif in the context of the full protein resulted in reduced surface 
expression, and a loss of functionality. The L/I zipper was found to be present 
in 140 paramyxo- and pneumovirus fusion protein TMDs. This work examines 
whether wh  iimporether the importance of the L/I zipper in the context of another paramyxvovirus. We
used the model system, PIV5 F to dissect the role of the TMD L/I zipper 
in expression and fusogenic activity. We found that the (L/I) zipper plays important roles in 
functionality of the PIV5 F protein, but not surface expression of the protein. 
Following membrane merging, a series of events occur that facilitate the 
release of viral contents into the host cell. The NNS RNA carried by the virus 
into the cell is used as a template for viral replication and transcription; two 
important steps in generation of viral progeny. In the life cycle of NNS viruses, 
viral proteins assume multi-functional roles to optimize their replication and 
spread. One of the key players during the course of infection is the matrix 
protein (M). The matrix protein has been identified as a master regulator of viral 
infection with most studies focusing on its roles in late-stage infection, during 
assembly and budding of viral progeny. The matrix proteins of many enveloped 
viruses have been shown to associate in high order oligomers to form a grid- 
like array underneath the plasma membrane, where they can induce 
membrane curvature to allow for the budding of viral particles. Not surprisingly, 
the absence of M in some NNS RNA viruses results in a significant viral titer 
decrease. Interestingly, some recent studies show that the matrix protein has 
other critical roles in viral infection such as immune modulation and host cell 
translation antagonism. One of these newly uncovered roles for viral matrix 
proteins involves the regulation of viral RNA synthesis. Studies with EBOV and 
MeV demonstrate that the matrix protein is involved in early infection events, 
as inhibits viral replication. To study the roles of the HMPV M protein in early 
infection, we performed a spatiotemporal analysis of M in HMPV-infected cells. 
We noted the presence of HMPV M within the nucleus during early infection. 
Our knockdown studies of HMPV M indicate that HMPV M is a positive 
regulator of viral replication and transcription, as in its absence, the rates of 
mRNA and viral genomic RNA synthesis are dramatically reduced. Additionally, 
within the NNS RNA virus order, HMPV M is the only matrix protein found to 
bind calcium. We created alanine mutants to the calcium coordinating residues 
of HMPV M and found that these residues were important in properly folding 
the protein. Together, these findings contribute to our understanding of the 
mechanisms of NNS RNA viral infection. 
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protein; Membrane fusion; Viral replication. 
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Chapter 1: BACKGROUND AND INTRODUCTION 
Pathophysiology of NNS RNA viruses 
Non-segmented negative sense (NNS) RNA viruses display a wide range 
of pathogenicity in their hosts. [1]. Hendra virus (HeV), Nipah virus (NiV), rabies 
virus (RV), and Borna disease virus (BDV) can infiltrate the central nervous 
system, resulting in encephalitis and other serious neurological symptoms [2-4].  
Additionally, paramyxoviruses and pneumoviruses are some of the leading 
causative viral agents of respiratory tract illness [5, 6]. For example, infection with 
respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) typically 
result in bronchiolitis but can also manifest as more severe symptoms that may 
require mechanical ventilation and/or cardiovascular support [7]. RSV and HMPV 
infections are common in pediatric populations, and studies show that most people 
by the age of 5 have already been infected; however, re-infections occur 
throughout life [8]. HMPV and RSV also result in significant morbidity and mortality 
in the elderly and immunocompromised [9-11]. Additionally, human parainfluenza 
virus (hPIV) 1 and 3 pose significant health risks in lung transplant patients [12], 
while PIV5 is non-pathogenic in humans but serves as a potent viral model system 
for paramyxo-and pneumovirus studies [13, 14]. Other NNS RNA viruses such as 
EBOV, for instance, affect the vascular system of non-human primates and 
humans, potentially leading to hypervolemic shock, and can result in multi-organ 
failure and resulting in a 25-90% fatality rate. Although some NNS RNA viruses 
such as RV and measles virus (MeV) have effective vaccines [6, 15-17], for many 
NNS RNA viruses, despite multiple ongoing trials, there are currently no FDA-
approved vaccines and therapeutics for humans, and much of their treatment 
involves supportive therapy [6, 18-22]. However, in a positive turn of events, a 
three-antibody cocktail treatment against EBOV, REGN-EB3, was approved in 
October 2020 [23], highlighting important strides in NNS RNA viral research. 
Together, the current literature points out a dire need for a more detailed 
understanding of the molecular details of NNS RNA viral infection to elucidate 
novel therapeutic targets. 
2 
Public health impacts of NNS RNA viruses 
While the impacts of positive stranded RNA viruses such as the newly 
emerged SARS CoV-2 are at the forefront currently, NNS RNA viruses have also 
historically contributed to severe disease not only in humans, but also in livestock, 
plants, and fungi [2, 3, 24, 25]. Ebola virus (EBOV), RSV, and the re-emerging 
MeV are some high-profile examples of NNS RNA viruses that have caused global 
public health concern [26-28]. Although some NNS RNA viruses such as RV have 
been present for centuries [3], the vast majority of emerging viruses are RNA 
viruses [29]. With a tendency to jump from other species to humans, NNS and 
other RNA viruses exploit a naïve host cell population with limited cross-immunity 
to inflict deleterious effects  [4, 29, 30]. 
Classification and morphology of NNS RNA viruses 
NNS RNA viruses belong to the order Mononegavirales which consists of 
eight families: Bornaviridae, Filoviridae, Mymonaviridae, Nyamiviridae, 
Paramyxoviridae, Pneumoviridae, Rhabdoviridae, and Sunviridae [31]. These 
viruses are enclosed in a host-derived viral membrane, with a spherical, rod-like, 
filamentous, or pleomorphic morphology [1, 2, 24, 25]. Their continuous negative 
stranded genomes are up to approximately 19kb in length and encode between 5-
10 genes [32, 33]. Some genes encode proteins directly involved in the viral 
structure while others have non-structural properties. In general, the RNA is 
arranged from 3N-P-M-G-L5; however, some NNS RNA viruses contain other 
proteins such as SH, M2, NS, and additional as-yet uncharacterized proteins [31-
33] (Figure 1.1).
The RNP complex of NNS RNA viruses 
NNS RNA genomes are encapsidated in a long, flexible, helical 
ribonucleoprotein (RNP) complex, composed mainly of the nucleoprotein (N, NP) 
functioning in close association with the RNA dependent RNA polymerase (RdRp) 
complex. The RdRp is made up of the large protein (L) and the polymerase 
cofactor phosphoprotein (P) [32, 34]. N/NP functions primarily by enclosing the 
viral RNA in a continuous protein chain, providing protection against nucleases 
3 
[35], and allowing for the encapsidated NNS RNA to be used as a template for 
both transcription and replication [32, 35]. This N/NP protein coat also circumvents 
innate immune recognition such as responses from Toll-like receptors, Rig-I, and 
interferon mediated response that may otherwise identify and respond to degrade 
foreign RNA species in the host cell [34-36]. P is a multifunctional protein, and one 
of its roles is to serve as a cofactor the for the viral polymerase [37]. It is also 
reported to interact with host cell factors [38, 39]. For P, phosphorylation states, as 
well as the extent of phosphorylation, play significant roles in viral replication and 
in its interactions with other viral proteins and/or host factors  [39, 40]. L, the largest 
viral protein has RNA dependent RNA polymerase activity, and in concert, N, P, 
and L facilitate viral replication of the NNS RNA viruses.  [31, 35]. 
Surface glycoproteins of Paramyxo-and Pneumoviruses 
Since NNS RNA viruses are enveloped, infection requires the energetically 
costly process of fusing the viral membranes with their host target cells [41-43]. 
While some NNS RNA viruses encode a single protein G/GP that facilitates both 
attachment and fusion, most require two distinct proteins to engage the process. 
In general, the fusion protein (F) and attachment protein (G, GP, HN, or H) are 
critical for entry of viruses into host cells—the attachment protein interacts with 
cell-surface receptors to enable a virion to tether to a host cell. Then, after a virion 
is oriented closely with a host cell, the fusion protein undergoes essentially 
irreversible conformational changes to merge viral membranes with host cell 
membranes [44-47]. F and G/GP/HN/H are the two surface glycoproteins present 
on most NNS RNA viruses, are recognized by the host cell as antigens and thus 
often serve as attractive antiviral targets [33, 47-49]. In addition to the fusion and 
attachment proteins, some viruses such as parainfluenza virus 5 (PIV5), HMPV 
and RSV have the small hydrophobic (SH) protein, which is a proposed viroporin 
for HMPV and RSV [50, 51].  
The attachment protein 
In addition to roles in antigenicity, viral attachment proteins are important 




host cellular membranes [52]. Paramyxo- and pneumo-virus attachment proteins 
are generally classified as type II membrane proteins with a globular head, a stalk, 
a transmembrane domain and a cytoplasmic tail [53]. 
Although paramyxo- and pneumo-virus attachment proteins exist as 
homotetramers (dimer-of-dimers), each monomeric unit can bind to its respective 
receptor molecule. In addition, certain paramyxo- and pneumo-virus attachment 
proteins can recognize and bind sialic acid on host cell receptors. Indeed, the 
designated names, H, HN, or G are based on their binding and/or catalytic activity 
with sialic acid on the cell surface. For instance, hemagglutinin (H) mediates 
hemagglutinin activity by binding to sialic acid; hemagglutinin-neuraminidase (HN) 
mediates both hemagglutinin and neuraminidase by binding and cleaving sialic 
acid; and glycoprotein (G) neither binds nor cleaves sialic acid. Instead, for some 
viruses, G can bind ICAM, heparan sulfate, or other glycosaminoglycans. NiV and 
HeV G proteins bind to ephrinB2 or ephrinB3 [53]. Interestingly, MeV H also 
recognizes and binds to CD46, SLAM (CDw150), and nectin-4 on host cell 
surfaces [46, 54, 55].  
For paramyxoviruses, the viral attachment protein function not only 
precedes fusion protein conformational changes, but also in essence triggers the 
beginning of the fusion process mediated by the fusion protein. Aguilar et al. review 
five mechanisms through which the attachment protein directly interacts with F, 
and undergoes conformational changes that consequently start the fusion protein 
activity [53]. However, it is also critical to note that for HMPV and RSV, despite the 
overall conserved architecture with other paramyxo- and pneumovirus attachment 
proteins [53], G is not required for infection to occur in cell culture and in an animal 
model [56, 57]. To that, Chang and Dutch also detail five roles the attachment 
protein may have in triggering the fusion protein, either by direct interaction with 





The small hydrophobic protein 
The SH gene is expressed by a select number of NNS RNA viruses such 
as PIV5, HMPV, RSV, mumps virus (MuV), J paramyxovirus (JPV), and Tupaia 
rhabdovirus (TRV). Despite SH being present in all primary isolates in HMPV for 
example, SH deletion is neither beneficial nor detrimental for entry, replication, or 
spread in the cell culture and animal models that have been examined [50]. For 
RSV and HMPV, SH forms higher order structures, can localize to the plasma 
membrane, and is shown to increase plasma membrane permeability [50, 51]. 
Additionally, RSV SH forms non-selective cation channels that are permissive to 
Na+ or K+ [51]. These data present SH as a potential viroporin. 
Studies have also reported that SH regulates cytopathic effects (CPE) in 
PIV5. A recombinant PIV5 virus lacking the SH gene showed an increase in TNF-
α-induced apoptosis, suggesting that SH inhibits apoptosis and consequent CPE 
in infected cells [58]. Indeed, further research in RSV also suggest similar functions 
of SH in preventing virus-induced apoptosis as a host immune response, though 
these studies did not directly implicate TNF-α [51], pointing to perhaps multiple 
pathways by which SH acts to protect against CPE and sustain infection in intact 
cells. Surprisingly, HMPV SH has been shown to co-immunoprecipitate with F, and 
drastically suppress the fusion activity in fusion reporter system [50]. 
The fusion protein 
Although paramyxoviruses typically couple receptor binding with host cell 
membrane fusion at the plasma membrane [46], the pneumoviruses HMPV and 
RSV can enter cells through clathrin-mediated endocytosis, or through induction 
macropinocytosis of the full viral particle [56, 59-61]. For some strains the HMPV 
F protein is triggered by low pH within endosomes (Figure 1.2). For these viruses 
the triggering of the fusion protein is nuanced: even though the post-fusion form is 
energetically favored, F mainly exists on cell surfaces in the pre-fusion form, 
suggesting an intricate balance in maintaining prefusion conformation until 
productive triggering can occur. Indeed, as previously described, the attachment 




change the F protein microenvironment to start a cascade of events that trigger 
the fusion protein. Alternatively, F may bind its own receptor, and act 
independently of G, as is shown for HMPV and RSV. 
Paramyxo- and pneumoviruses, are synthesized as inactive F0 forms, 
folded into homotrimers within the endoplasmic reticulum (ER), and trafficked to 
the plasma membrane. For PIV5 F activation, furin cleaves F0 within the trans Golgi 
network (TGN) while F traverses the endocytic pathway before it is expressed on 
the cell surface in the disulfide-linked fusogenically active form, F1 + F2. In other 
cases, such as with HeV and NiV, F0 is first expressed on the cell surface, then is 
signaled to be endocytosed and cleaved by cathepsin L in the early endosomes 
and returned to the plasma membrane to mediate fusion. HMPV F can be cleaved 
by TMPRSS2, HAT, matriptase, KLK5, and trypsin in cell culture [62, 63] (Figure 
1.3). Even after proteolytic cleavage, F1 + F2 is maintained in a metastable 
conformation until it is triggered to undergo dramatic, essentially irreversible 
conformational changes into a more energetically stable post-fusion conformation. 
These large conformational changes are coupled with merging the viral and host 
cell membrane, thereby reducing the activation energy required to merge the 
membranes and create a fusion pore. The fusion pore is subsequently expanded 
to allow for the mixing of viral and cellular contents (Figure 1.4). 
 F proteins are class I fusion proteins that form homotrimers. Each monomer 
contains a fusion peptide FP, heptad repeats A and B (HRA and HRB), a single-
pass transmembrane domain (TMD), and a cytoplasmic tail (CT) (Figure 1.3). With 
the help of a trimeric coiled-coil domain (GCNt) attached to the HRB in lieu of the 
TMD and CT, Yin et al. successfully crystalized the first prefusion form of a 
paramyxovirus F, PIV5 F. The prefusion structure of F consists of a large globular 
head domain and a trimeric coiled coil. The proteolytic cleavage reveals the FP, 
which is proximal to the HRA and larger (F1) segment. The FP, HRA, and F1 + F2 
form the globular head domain, and it is supported by the HRB which forms the 
trimeric coiled coil stalk. The TMD and CT would be immediately adjacent to the 




    When triggered, the cleaved form of F inserts its fusion peptide into the host cell 
membrane, forming a prehairpin fusion intermediate structure. With the FP being 
proximal to HRA, in the transient prehairpin structure, the HRA is also released 
from the globular head, stretching towards the target cell membrane. In this 
intermediate structure, HRB remains pinned adjacent to the viral membrane. 
Because of its unfavorably high energy state, the prehairpin intermediate 
subsequently folds upon itself, driving the FP and HRA towards HRB to form a six-
helix bundle (6HB) in a hairpin post-fusion structure. This dynamic process is 
hypothesized to provide the energy to merge the two membranes (Figure 1.4). 
The transmembrane domain of the fusion protein 
 Although initially postulated to be merely a membrane anchor, the TMD of 
paramyxovirus F proteins has been shown to be important in function. For 
example, the TMD plays key roles in signaling for endocytosis and recycling of the 
HeV fusion protein, a critical process without which F would remain fusogenically 
inactive [66]. In addition, key residues within the TMD and CT tail were found to be 
important for formation of virus-like particles (VLP)s. F protein cleavage alone is 
not sufficient for VLP formation, as there was a clear reduction in the incorporation 
of a trafficking mutant of Hendra F into VLPs when compared to the wild type (WT) 
protein [67]. Moreover, replacement of Newcastle disease virus (NDV) F TMDs 
with TMDs from other closely related viruses resulted in fusion-dead proteins that 
could no longer associate with their homotypic attachment protein. For NDV, the 
specific TMD sequence is an important factor in maintaining the structural integrity 
of the fusion protein [68]. Furthermore, a study of RSV F revealed that the TMD is 
important for localizing the protein onto the apical surface in polarized epithelial 
cells [69]. 
A 2005 study of the hPIV3 fusion protein revealed that removal of the TMD 
resulted in the formation of a 6HB and the isolation of F in the post-fusion 
conformation [64]. This unexpected finding suggests that the TMD is important in 
maintaining the metastable pre-fusion conformation of the F protein. However, 




PIV5 in its pre-fusion form [65].  In fact, when isolated, the TMD of PIV5 F, HMPV 
F, and HeV F associate in a monomer-trimer equilibrium [70]. Moreover, when the 
proximal HRB was added to the TMD of HeV F, the TMD-TMD interactions were 
weakened [71], suggesting that the TMD important for maintenance of the fusion 
protein trimer. Solid-state NMR and SAXS data have been used to generate a 
model of the TMD structure. In this model, for each monomer, there is a helical 
coiled coil which is flanked by two β-strands, creating a stand-helix-strand. The β-
strand termini are suggested to be critical for inducing membrane curvature and 
advancing fusion, whereas the α-helical segment of the TMD is rich in β-branched 
residues, which are important to drive trimeric interactions [72, 73]. 
The transmembrane domain leucine/isoleucine zipper 
To understand the mechanisms through which TMDs support trimeric 
association of fusion proteins, an analysis of 19 paramyxoviruses yielded 140 
TMDs which contained β-branched residues in a heptad repeat pattern. 
Specifically, a leucine/isoleucine (L/I) zipper was found in the TMDs of several 
paramyxo- and pneumoviruses, including HeV, PIV5, HMPV, and RSV, among 
others. Further studies demonstrated that for HeV F, the TMD is important for 
surface and total expression, stability, and fusogenic activity of the fusion protein. 
These data indicate that within the TMD, the L/I zipper is an important association 
and functional domain for HeV F activity. Indeed, when analyzed in isolation, the 
L/I zipper was found to be an important driver of trimeric association— F proteins 
lacking the TMD L/I zipper were found to have a greatly reduced trimeric 
association compared to the wild type protein [74], suggesting a likely mechanism 
through which the L/I zipper contributes to stabilizing the trimeric metastable 







The matrix protein of NNS RNA viruses 
Even at early stages during infection, the matrix protein interacts with viral 
proteins and host key host factors to facilitate viral entry. Recent literature indicates 
that as early as between 6-12 hours post-infection, the HMPV genome is actively 
transcribed into mRNA, in the process termed transcription, which is then used as 
a template to generate viral protein [75]. At the same time, the HMPV negative 
sense genome is used as a template to create a positive sense RNA antigenome, 
which, unlike mRNA, is it not capped and polyadenylated., The L protein uses this 
antigenome as a template to generate more negative sense viral genomic RNA 
(vRNA) [35, 75], a process known as replication. These viral replication and 
transcription events occur in punctate structures within the cytoplasm termed 
inclusion bodies, viral factories, or in the case of rabies virus, Negri bodies [76-80]. 
For the HMPV, inclusion bodies coalesce in an actin-dependent manner and are 
important for efficient viral replication and translation [75]. Importantly, the M 
protein can interact with N, and consequently with the RNP, as well as with the 
cytoplasmic tails of F and G, which allows M to recruit RNPs to the plasma 
membrane for assembly into viral particles [44].  Furthermore, for many viruses, 
the M protein alone can form authentic looking virus-like particles (VLPs), 
suggesting that it plays a critical role in viral morphogenesis [44, 81, 82] (Figure 
1.5 and Figure 1.6). 
The general architecture of matrix proteins across Mononegavirales 
Figures 1.7 and 1.8 show that despite the low sequence conservation 
across the family, there is a degree of sustained structural similarity, suggesting a 
possible convergent evolutionary relationship that would explain similarity in their 
function during their respective life cycles. For paramyxoviruses, even though the 
primary M protein sequences are not conserved, studies show that their structures 
are similar, with two characteristic orthogonal β-sandwiches, flanked by α-helices. 
[44, 83]. Importantly, Chatterjee et al. discovered that the NS1 protein of RSV, 
which is a strong inhibitor of transcription and replication [84] as well as a potent 
suppressor of the innate immune response [85], bears a β-sandwich structure that 





Structural plasticity is important for the function of pneumovirus matrix 
proteins 
In infected cells, paramyxovirus M forms an ordered layer on the 
cytoplasmic side of the plasma membrane [44], and HMPV M interacts with the 
membrane through its concave surface [83, 87]. The EBOV matrix cognate VP40 
contains a hydrophobic patch that inserts into the plasma membrane. In addition, 
VP40 contains a positively charged domain which selects for plasma membrane 
phosphatidylserine (PS). Although VP40 traverses to the membrane as a dimer, 
after association of PS it forms a higher order filamentous oligomeric structures 
that induce membrane curvature [81]. Similar to EBOV M, HMPV and RSV M exist 
in a dimeric form but also oligomerize to form filaments in the presence of lipids 
[83, 88]. Interestingly, Leyrat et al. have shown that the N-terminal domain of 
HMPV contains a high affinity Ca2+-binding site, a feature that has not been 
reported for other viral M proteins. When HMPV M binds Ca2+, it induces a 25⁰C 
increase in melting temperature, likely increasing the structural rigidity, thereby 
possibly contributing the structural stability of matrix oligomers for more efficient 
budding facilitated by the M protein [83].  
Nuclear entry of some NNS RNA viruses 
With exception of Bornaviridae, NNS RNA viral replication and transcription 
is well-documented to occur in the cytosol. Curiously, despite this, several reports 
show that the matrix proteins of NNS RNA viruses including Newcastle disease 
virus (NDV), vesicular stomatitis virus (VSV), Sendai virus (SeV), as well as 
Hendra (HeV) and Nipah virus (NiV) are trafficked to the nucleus during the 
infectious cycle [89]. This nuclear entry is unlikely to result from free diffusion of 
the protein through the nuclear pore, since most matrix proteins exist dimers or 
higher order structures that exceed the 50kDa upper limit to passively traverse the 
nuclear pore complex [82, 83, 87, 88, 90, 91]. Instead, for some viruses such as 
NiV M, there is a bipartite nuclear localization sequence which is recognized by 
importin-α that regulates nuclear entry and a well-documented nuclear export 





Unlike most viruses that belong to the mononegavirales order, Borna 
disease virus (BDV) is well-documented to have a nuclear step in viral replication. 
As reviewed by Honda et al., like other NNS RNA viruses, BDV M binds to viral 
RNPs [92, 93]. Interestingly, the group discusses results which demonstrate that 
BDV M binds to and facilitates the nuclear to cytoplasmic shuttling of the BDV 
RNPs, better orienting them for assembly [93]. Given this observation, and given 
that BDV M is very similar to the N terminal domain of EBOV VP40 [94], it is 
possible that the other NNS RNA viruses that do not require a nuclear step during 
replication have a conserved evolutionary step in maintaining the nuclear sojourn, 
but in this case with M only; however, since viruses evolve to fine-tune their protein 
functionalities, and since distinct roles for nuclear entry have been outlined for 
certain viruses such as NiV and RSV [90, 95], it is unlikely that other NNS RNA 
viral matrix protein nuclear import is completely benign. It is however important to 
note that not all NNS RNA viral matrix proteins have a nuclear step during infection. 
Matrix nuclear entry supports modification for intracellular signaling, 
oligomerization, or membrane association. 
While within the nucleus, SeV M and NiV M are modified by ubiquitin. The 
ubiquitin modification on NiV occurs on a critical lysine residue, K258, within the 
NLS. Replacing K258 with arginine, which maintained the positive charge and thus 
allowing nuclear entry but not the ability to be ubiquitinated, led to an accumulation 
of NiV K258R M in the nucleus, resulting in a dramatic reduction in viral budding 
and spread [89]. It is tempting to assume the reduced cytoplasmic levels of K258R 
M available after nuclear accumulation was the sole determinant of this reduced 
budding and spread. However, when nuclear import of NiV M was blocked 
altogether with a K258A mutation, NiV K258A M was only present in the cytosol, 
but did not associate with membranes. 
 
 To further understand the role of ubiquitin in NiV M membrane association, 
the authors created a NiV K258R M-ubiquitin fusion protein. This fusion protein 
allowed M to be duly imported to the nucleus but prevented ubiquitination at the 




accumulation phenotype and allowed export of protein, despite the K258R 
substitution. While it was expected that the ubiquitin-rescued K258R mutant would 
result in plasma membrane localization, notably, this mutant also failed to localize 
at the membrane [89, 90, 96]. The authors therefore speculated that either both 
the K258A and the K258R-ubiquitin NiV M mutants block interaction with important 
host factors that normally allow for additional post-translational modifications that 
functionalize M or that ubiquitination regulates both the oligomerization interface 
and the membrane interaction of M, allowing it to form the characteristic helical 
filamentous ordered layer underneath the plasma membrane [89, 90]. 
Nevertheless, these data also suggest that majority of newly synthesized M 
relocates to the nucleus providing more evidence to suggest a nuclear function 
during infection. While the ubiquitination of M has only been documented for 
certain paramyxoviruses, it does not exclude the possibility that other post-
translational modifications may occur which are not specific to the nucleus. These 
data also beg the question of why this specific modification must happen in the 
nucleus, with the abundance of E3 ligases in the cytosol. 
Matrix protein nuclear localization allows for interaction with splicing 
machinery 
Studies show that for the paramyxoviruses SeV, MuV, NiV, and HeV, in 
addition to localizing to the nucleus, M is specifically imported to the nucleolus [89]. 
For these paramyxoviruses, immunofluorescence studies revealed that both WT 
and the aforementioned K258R mutation result in localization within the nucleolus; 
however, the K258R mutant accumulated within the nucleolus to a higher degree 
than WT. These studies showed that NiV M is detected within the nucleus as early 
as between 8 and 16 hpi, primarily within punctate structures consistent with the 
nucleolus [96]. It is currently unclear the mechanisms behind the nucleolar 
targeting of paramyxovirus matrix proteins. However, biochemical studies support 
this nucleolar association, as NiV M was shown to interact with upstream binding 
factor F (UBF), a transcription factor particularly associated with recruiting 





 In addition, RSV M and HeV M have been associated with the nucleolar 
protein nucleophosmin (Npm) B23 [97, 98]. UBF and Npm B23 are known to be 
associated with ribosomal proteins, and thus may suggest a role between matrix 
proteins and ribosomal biogenesis [98]. The nucleolus is the hub of ribosomal 
biogenesis [99], which may suggest the role of several NNS RNA viral matrix 
participation in co-opting host translational responses; however, the nucleolus also 
serves as a central processing unit of stress response [99]. Similarly to non-
membrane-bound cytoplasmic units such as stress granules, P-bodies, and viral 
inclusion bodies, it is possible that the nucleolus undergoes liquid-liquid phase 
separation (LLPS) in response to variable cellular environments (such as stressors 
associated with heat shock, viral infection, or protein aggregation). 
 
 Furthermore, not only was fibrillarin, a nucleolar protein found to be critical 
for Henipavirus infection, but also, specifically, methylation of fibrillarin is essential 
for viral RNA synthesis. Thus, fibrillarin may be important in proviral RNA synthesis 
mechanisms and its association with pre-ribosomes and NOP56 or NOP58 [100] 
could point to methyltransferase activity of host nucleolar enzymes being of 
particular importance to certain NNS RNA viral infections. These may suggest a 
novel druggable target. These findings may not exclude the idea that the matrix 
protein may also in fact interact with other ribosomal biogenesis machinery to 
prevent targeting of other important host cellular proteins form being synthesized. 
It is possible M also associates with hnRNPs, and other spliceosome machinery.  
Nuclear matrix protein usurps critical cellular processes 
Viral infections notably co-opt cellular processes for their own proliferative 
benefit. Earlier studies showed that VSV M is instrumental in rapidly shutting down 
host cell macromolecular synthesis including mRNA and proteins. Experiments 
showed, that independent of other viral proteins, VSV M has profound inhibitory 
effects on host cell-directed mRNA and snRNA synthesis [101, 102]. This inhibitory 
role of M is also genetically distinct from its canonical roles in viral assembly and 
budding [103]. Upon further investigation, the nuclear import of VSV M was found 




the nuclear pore complex (NPC) [101], alluding to a role for M in mediating 
nucleocytoplasmic shuttling of host macromolecules. Indeed, the presence of M in 
Xenopus laevis oocytes highly mimics Ran-GTPase deficiency, and thus was 
hypothesized to interfere with Ran-GTPase-dependent nucleocytoplasmic 
shuttling [104].    
Nuclear entry of matrix protein supports immune modulation 
Unlike RSV, HMPV does not have the NS1 and NS2 proteins, however it is still 
pathogenic. Evidence suggests that while sequence conservation is low, the 
secondary structures of RSV NS1 and RSV M are similar: NS1 resembles one half 
of the orthogonal beta sandwich that constitutes the RSV M protein. When 
compared, RSV NS1 showed a high degree of alignment with the N-terminal 
domain of RSV M (RMSD 3.78 Å over 96 residues). Moreover, RSV NS1 is also 
structurally similar to EBOV VP40 and Newcastle disease virus (NDV) M despite 
low sequence similarities. Based on their data, Chatterjee et al. speculate that a 
potential duplication event of the N-terminus of M gave rise to the NS1 protein, 
which then divergently evolved its functions in immune modulation [86]. These data 
suggest a conserved functional significance in the structural fold of the NS1 and 
some NNS RNA M proteins. NS1 is a potent immunomodulator; however, most of 
its reported function is in facilitating inflammatory responses, IFN antagonization, 
and inhibition of dendritic cell maturation arise from the C terminal α-helix, which 
is the portion of the RSV NS1 structure that differs from HMPV M.  
The matrix protein regulates viral transcription and translation  
Transcription 
Matrix proteins of NNS RNA viruses play important roles in regulating 
transcription and replication of viral genomes: BDV, rabies virus (RV), and measles 
virus (MeV), matrix proteins inhibit viral transcription. For these viruses, M binds to 
and condenses viral RNA, making it less accessible as a template for transcription 
[94, 105, 106]. Curiously, for RV, as M inhibits viral transcription, it performs an 
opposite stimulatory role in replication [105]; providing insight into how 





Further work on RV M pinpointed residue 58 as important in interacting with 
the viral polymerase and consequently on downstream effectors that facilitate the 
switching viral transcription-viral replication gradient. Importantly, this data 
highlight that mutations at residue 58 do not affect assembly and budding, further 
elucidating a distinct role of M outside of the classical budding and egress [107]. 
In terms of regulation, it is hypothesized that because transcription and consequent 
translation of viral proteins is prioritized upon entry since genomes require 
encapsidation [32, 34-36], a critical concentration of matrix protein in the cytosol 
would inhibit transcription. This inhibition of transcription may allow the viral 
polymerase to favor replication of the viral genome. Indeed, nuclear sequestration 
of M coincides with an increase in mRNA production and nuclear exit is consistent 
with decreased mRNA for RSV [87, 95, 108].  
Replication 
Interestingly, studies on EBOV, MeV, and RSV suggest that increasing 
amounts of M is detrimental for viral replication.  Viral reporter gene assays 
suggest that in the presence of increasing M, there is a correlative decrease in 
viral replication [95, 106, 109]. Like with the transcription model, this may point to 
a role for sequestration of M in the nucleus to allow for an increase in viral 
replication. It is not far-fetched to postulate such a mechanism would result in the 
gradual cessation of viral replication at the time that M is also gradually exported 
from the nucleus to prepare nascent virions for assembly. 
 
 This phenomenon also applies to influenza A virus, which belongs to the 
family Orthomyxoviridae, an RNA viral family whose genomes are encoded in 
multiple segments. Influenza A has an obligate nuclear stage and  a matrix cognate 
which supports viral transcriptase negative regulation [110]. It is possible that this 
is an evolutionary or functionally conserved function. Moreover, the presence of M 
may mark the beginning of assembly, and its nuclear shuttling sequesters M away 




counterparts, there is currently no evidence that Henipa matrix proteins affect viral 
replication and transcription, despite being trafficked to the nucleus [89].  
The unique calcium binding site of HMPV M 
In 2014, Leyrat et al. published the crystal structure of HMPV M, which was 
surprisingly found to have a calcium binding site [83] (Figure 1.7).They found that 
calcium (Ca2+) had a role in the structural stability of M, and also speculated on 
whether this Ca2+ association plays a role in the contacts between M and N, 
possibly influencing which point in the viral life cycle assembly occurs [83]. 
Furthermore, reports show that RSV M is translocated into the nucleus during 
infection, and the function of this sojourn is currently unknown [95, 111]. However, 
RSV M is known to contain RNA-binding properties [112], and this may modulate 
interactions with host cell nucleic acids. Compared to mammals, viruses such as 
HMPV and RSV have a relatively small proteome, encoding 9 and 11 proteins 
respectively [9, 113]. However, there are still many functions involving viral 
proteins and the viral genome within infected cells that are not yet well understood. 
Calcium signaling may be important component in viral spread 
Ca2+ plays important roles in paramyxo- and pneumoviral infection and 
spread. For example, in the absence of Ca2+, RSV infectious virus yield was slightly 
reduced, and cell fusion and syncytium formation was ablated [114]. Another study 
corroborated this observation that RSV requires Ca2+ for efficient spread in cell 
culture [115]. In addition, when exposed to low Ca2+, production of SeV was 
suppressed in infected LLC-MK2 cells. Furthermore, Ca2+ was found to be critical 
for cell surface expression of SeV glycoproteins. In low Ca2+ conditions, viral 
glycoproteins were accumulated within the Golgi. When normal Ca2+ conditions 
were restored, the otherwise accumulated SeV glycoproteins, cell surface 
expression of SeV glycoproteins was quickly rescued, and consequently, Sendai 





Calcium binding may support conformational changes that could allow for 
membrane association, oligomerization and/or fortification of the viral 
capsule. 
Amarasinghe and Dutch discuss the possibility that Ca2+ binding leads to 
additional conformational changes within HMPV M that potentially regulate 
interactions with (a) host or viral factor(s). Although M interacts with the plasma 
membrane through its highly positively charged CTD, it is possible that Ca2+ 
binding at the NTD would lead to conformational changes that could extend to the 
CTD to potentially affect membrane association, as well as the interactions of M 
with the CT tails of the surface glycoproteins. Moreover, if Ca2+ binding in HMPV 
M affects protein-protein and/or protein-lipid interactions, then it is likely that viral 
infection may regulate the intracellular Ca2+ environment to favor viral infection 
[117]. Indeed, the ability of HMPV M to bind Ca2+, and the consequent induction of 
increased thermostability suggest that Ca2+ plays roles in stabilizing viral particles 
as they traverse the Ca2+-rich extracellular environment. This phenomenon may 
confer an advantage in the lifespan of the virus. [83]. Additionally, since the Ca2+ 
binding site faces away from the membrane, there is a possibility that variations in 
Ca2+ concentrations inside infected cells at various stages of the viral cycle 
regulate the assembly of viral nucleocapsids onto M arrays at viral budding sites; 
but there is also a possibility of its involvement in intracellular transport of M 
proteins to the membrane [83]. 
Dissertation overview 
 The current COVID pandemic brings to light the devastation that relatively 
small biological entities such as viruses can wreak on the global population. Even 
so, concerted advancements in science to generate world-saving vaccines 
highlight how critical viral research is. NNS RNA viruses are major contributors to 
emerging viruses, pinpointing the specific need to dissect their mechanisms of 
infection. Events that lead to successful entry, replication, transcription, and spread 
of viral agents are important in the understanding and identification of novel 
therapeutic targets. Moreover, understanding the mechanisms of viral infection 
can also provide more insight into non-pathogenic cellular processes, allowing for 




in mind, the Dutch lab studies the fusion, entry, establishment of infection, and 
egress of paramyxo- and pneumoviruses, two families containing pathogens of 
worldwide importance. For the fusion studies, we focus on the biochemistry and 
biophysical properties of the main fusion catalyst, the fusion (F) protein. My work 
focuses on PIV5 F, a model paramyxovirus. Our work on established infection 
focuses on unique mechanisms to which cells react to viral pathogens. In addition, 
I have studied the HMPV matrix (M) protein to dissect its roles in progression of 
infection. 
 HMPV and PIV5 are enveloped viruses, and as such need to undergo the 
energetically unfavorable process of merging their membranes with host cells 
before they can successfully infiltrate them. For these viruses, this process 
requires the fusion protein. Fusion proteins have been extensively studied, and 
much of their mechanisms of action can be detailed; however, there are still 
significant gaps in the field that warrant further research. For example, paramyxo- 
and pneumovirus fusion protein transmembrane domains were initially thought to 
solely be membrane anchors. However, studies showed that when removed or 
replaced, major changes in the folding and/or oligomerization of the rest of the 
protein occurred, suggesting more critical roles of the transmembrane domain in 
fusion function. Indeed, in isolation, the transmembrane domain of PIV5, HMPV, 
and HeV F are able to associate in trimeric form, indicating that the transmembrane 
domains also play roles in trimerization of full proteins.  
Additionally, an interesting phenomenon that occurs with viral fusion 
proteins is that they exist largely on the cell surface in a metastable pre-fusion form 
until the “trigger” for fusion occurs, allowing them to rearrange into a more 
energetically stable post-fusion conformation. While much is known about the 
conformational processes that occur with the fusion protein, much more work is 
needed to elucidate what maintains the metastable pre-fusion conformation. The 
Dutch lab has done previous work in identifying potential association motifs within 
the fusion protein transmembrane domain for a multitude of paramyxo- and 




leucine/isoleucine residues that were important for trimerization and fusion 
function of the HeV fusion protein. To build on these findings, in chapter 3, I 
address the functional relevance of the leucine/isoleucine zipper by testing 
whether it is important for another paramyxoviruses. Based on the works described 
in this chapter, I hypothesized that the transmembrane domain L/I zipper would be 
critical in the expression, turnover, and functionality of the PIV5 fusion protein. To 
address this hypothesis, I used the model system PIV5 to address the expression, 
fusion, and stability in the context of a mutated leucine/isoleucine zipper. Our data 
show that unlike with HeV fusion protein where expression is reduced, PIV5 fusion 
protein expression is maintained, while fusogenic activity is ablated. 
While studying the effects of actin on cytoplasmic inclusions with Dr. Nicolás 
Cifuentes-Muñoz, a former post-doctoral scholar at the Dutch lab, I became 
interested in the HMPV matrix protein. The matrix protein is a key element in viral 
assembly as it forms an ordered layer underneath the viral membrane, acting as a 
scaffolding protein allows the virus to bud and form viral particles which egress 
from host cells. In addition, matrix proteins are known to have important contacts 
with the RNP, as well as the cytoplasmic tails of the surface glycoproteins, 
orienting them with each other for efficient viral assembly. 
Although the vast majority of NNS RNA viral replication occurs in the 
cytosol, with no apparent roles for viral proteins within the nucleus, I noted that 
HMPV M indeed makes a nuclear sojourn. This is consistent with several other 
viral systems including the matrix proteins of the deadly HeV and NiV viruses. In 
chapter 4, I discuss the timing of nucleocytoplasmic transport, and address 
hypotheses involving the sequestration of the matrix protein within the nucleus at 
the heights of viral infection. Our work shows that when the matrix protein is 
knocked down with a peptide-conjugated phosphorodiamidate Morpholino 
oligomer (PPMO), inclusion body morphology and placement are perturbed. 
Importantly, we find that a lack of the matrix protein results in a drastic reduction 
in viral transcription and replication, with the mRNA of all viral proteins being 




hindered. Our results represent a novel finding that M early in infection is important 






Figure.1.1 The parainfluenza virus 5  particle, a prototypical paramyxovirus.  
A. The non-segmented negative sense NNS RNA genome is encapsidated by 
nucleoprotein (N), along with the polymerase complex that consists of the 
phosphoprotein (P) and the large protein (L). These altogether form the 
ribonucleoprotein complex RNP. The RNP is protected by a host derived 
membrane, studded with the fusion protein (F), the attachment protein with 
hemagglutinin and neuraminidase activity (HN), and the small hydrophobic protein 
(SH). The PIV5 genome also encodes the nonstructural protein (V) an immune 










Figure 1.2 The diversity of entry of paramyxo- and pneumoviruses. 
After engagement with a cell surface receptor or attachment factor, entry may 
occur by merger of the viral membrane with the plasma membrane at the cell 
surface (A), endocytosis of the full viral particle, where low pH within endosomes 
triggers membrane fusion (B), macropinocytosis, with the particle passing through 













Figure 1.3 Cleavage of the fusion protein.   
The fusion protein is initially expressed in a fusogenically inactive form F0 (top). 
For PIV5, the protein is cleaved within the trans Golgi network by furin into the 
fusogenically active disulfide-linked F0+F1 (bottom). For other viruses, F can be 
cleaved by cathepsin L within low pH endosomes, or once incorporated into viral 
particles or when on the cell surface by extracellular matrix proteases such as 
matriptase. The fusion protein consists of the F1 and F2 subunits (dark teal), the 
fusion peptide (FP, yellow), heptad repeat A (HRA, orange), heptad repeat B 
(HRB, light teal), the transmembrane domain (TMD, blue), and the cytoplasmic 






Figure 1.4. Conformational changes that occur during fusion. 
 Before signaling to begin the fusion process occurs, the fusion protein is held in a 
metastable prefusion conformation (A). As fusion is initiated, the fusion peptide 
inserts into the host cell membrane, extending the adjacent heptad repeat A region 
towards the host cell to form a prehairpin intermediate (B). Finally, the prehairpin 
intermediate folds upon itself, with the heptad repeats A and B forming a six-helix 
bundle and merging the viral and target cell membrane (C). This schematic shows 





Figure 1.5. The human metapneumovirus particle.  
A. Schematic of a HMPV viral particle. The host-derived membrane of the 
pneumovirus is studded with multiple copies of the fusion protein (F), attachment 
protein (G), and small hydrophobic protein (SH). Directly underneath the 
membrane is an ordered layer of matrix proteins (M). The core of the virus consists 
of the ribonucleoprotein complex, composed of the nucleoprotein (N), which 
encapsidates the negative stranded single sense RNA genome, the 
phosphoprotein (P), and the large protein (L), which is an RNA dependent RNA 
polymerase. The M2 gene encodes two additional proteins (M2-1 and M2-2), which 
play roles in polymerase processivity and immunomodulation. B. The arrangement 





Figure 1.6.The human metapneumovirus life cycle.  
Entry is initiated when the viral glycoproteins engage cell surface receptors (1). 
The viral particle is then endocytosed (2), where fusion occurs in low pH 
endosomes (3). As the genome is released, transcription (4) and replication (5) 
occur in discrete unenveloped compartments within the cytosol termed inclusion 
bodies. Following transcription, viral mRNA are exported from inclusion bodies, 
where they gain access to ribosomes to be translated (6). Following translation, 
the matrix protein is promptly delivered into the nucleus. The matrix protein can 
shuttle between the nucleus and cytoplasm (7). After the cell surface glycoproteins 
traverse the secretory pathway, the matrix proteins assemble them with viral RNA 
along with additional viral proteins. These assembled proteins bud into viral 
particles (8) and are released (9), prime for infection of other cells. In addition to 
release of nascent viral particles, HMPV induces the formation of extensions that 










Figure 1.7. Sequence and structure-based relationships of Mononegavirales 
matrix proteins.  
The relationships of mononegavirales matrix proteins based on (top) sequence 
similarity and (bottom) structure similarity. Top The evolutionary history was 
inferred using the Minimum Evolution method. The optimal tree is shown. The tree 
is drawn to scale, with branch lengths in the same units as those of the evolutionary 
distances used to infer the phylogenetic tree. The evolutionary distances were 
computed using the Poisson correction method and are in the units of the number 
of amino acid substitutions per site. The ME tree was searched using the Close-
Neighbor-Interchange (CNI) algorithm at a search level of 1. The Neighbor-joining 
algorithm was used to generate the initial tree. This analysis involved 13 amino 
acid sequences. All ambiguous positions were removed for each sequence pair 
(pairwise deletion option). There were a total of 383 positions in the final dataset. 
Evolutionary analyses were conducted in MEGA X. Bottom: Structural similarity 
dendrogram. The dendrogram is derived by average linkage clustering of the 





Figure 1.8. Similarity matrix heatmaps of Mononegavirales matrix proteins 
based on sequence and structural identity.   
Top: Sequence identity matrix generated in ClustalW2 and (bottom) structural 
identity matrix generated by DALI server based of matrix proteins as represented 






Figure 1.9. The human metapneumovirus matrix protein has a calcium 
binding site.  
Crystal structure of the HMPV matrix protein (right) showing residues that 
coordinate calcium binding (Glu 24, Asp 26, Leu 28, Lys 101). The diagram shows 
an adjacent Glu 103 that has not yet been shown to support calcium binding. 





Chapter 2 : MATERIALS AND METHODS 
PIV5 F Transmembrane domain project 
 
Cell lines and culture 
Vero cells were acquired from American Type Culture Collection (ATCC). BSR 
cells  were kindly provided by Karl-Klaus Conzelmann (Max Pettenkofer Institute), 
and BSR/T7 cells made by constitutively expressing T7 polymerase in BHK cells 
[118]  The cells were maintained in Dulbecco’s modified Eagle’s media, DMEM 
(Invitrogen), supplemented with 10% fetal bovine serum, FBS (Sigma). BSR cells 
were additionally maintained on 0.5 mg/mL of geneticin (Gibco) every third 
passage, to maintain selection of T7 polymerase. 
Plasmids and antibodies 
Plasmids with the PIV5 F or HN (W3A) were kindly provided by Robert Lamb 
(Howard Hughes Medical Institute, Northwestern University) and Hendra F or G-
containing plasmids were generously provided by Dr. Lin-Fa Wang (Australian 
Animal Health Laboratory). Mutants for the study were created using the 
QuikChange site-directed mutagenesis kit (Stratagene) in pGEM , and subcloned 
into the eukaryotic expression vector pCAGGS [119], for expression in Vero and 
BHK cells. For all the analyses, lipofectamine plus and plus reagent (Thermo 
Fisher) were used per manufacturer’s instructions. All constructs used were 
sequenced (ACGT) to ensure sequence integrity. For PIV5 F analyses, the 
cytoplasmic tail antibody, which detects residues 516-529 was used, and to detect 
pre-fusion PIV5 F species, mAb F1a kindly provided by Dr. Richard Randall 
(University of St. Andrews) were used. HeV F 5G7 antibodies were kindly provided 






Cells were seeded in 8-well chamber labtek plates (Thermo Fisher) to be at 
approximately 60-70% confluency for the next day. The following day, cells were 
transfected with 0.75μg of pCAGGS-MCS, pCAGGS-PIV5 F WT, or pCAGGS-
PIV5 F LIZ; pCAGGS-HMPV F WT or pCAGGS-HMPV F LIZ; and pCAGGS-HeV 
F WT or pCAGGS-HeV F LIZ. 24 hours post-transfection, cells were fixed in 4% 
paraformaldehyde (PFA) for 20 mins at room temperature, followed by 
permeabilization in 1% Triton X-100 for 15 mins at 4°C. Cells were then blocked in 
1% normal goat serum (NGS) in phosphate buffered saline (PBS), followed by 
incubation with their respective antibodies overnight (mAb F1a for PIV5 F, and anti 
HeV F 5G7 for HeV F) at 4°C. The next day, cells were washed seven times with 
0.05% Tween 20 in PBS, and incubated with FITC-conjugated secondary 
antibodies at 1:300 in 1% NGS for 1 hour at 4°C. The cells were washed again 
seven times with 0.05% Tween 20 in PBS, before being mounted with 
VECTASHIELD antifade mounting media with DAPI (Vectorlabs). Images were 
taken using a Nikon A1 confocal microscope and analyzed with NIS-Elements 
software. Images were processed with Adobe Photoshop with equivalent 
adjustments made to all channels. 
Time course radioimmunolabel assay 
Subconfluent Vero cells were transfected with 2.5 μg of pCAGGS-MCS, pCAGGS-
PIV5 F WT or pCAGGS PIV5 F LIZ in 6-well plates. The next day cells were 
washed twice with PBS and starved for 45 min at 37°C in cysteine-methionine-
deficient DMEM. Following the starve, cells were labeled for 30 minutes with 
Tran[35S] metabolic label (100 μCi/mL; MP Biomedicals). Following the label, cells 
were washed twice with PBS and normal DMEM was replenished on cells. At the 
indicated time points, the cells were washed three times with PBS and lysed with 
radioimmunoprecipitation (RIPA) lysis buffer (100 mM Tris-HCl, pH 7.4, 150 
mM NaCl, 0.1% SDS, 1% Triton X-100, 1% deoxycholic acid, 1 
mM phenylmethylsulfonyl fluoride (Sigma), and 25 mM iodoacetamide (Sigma)). 
Lysates were collected and centrifuged at 136,500 × g for 15 mins at 4°C, and the 




tail antibody 516-529 was added to each cleared lysate and incubated for three 
hours at 4°C with rocking. Antibody-conjugated PIV5 F in the lysate was 
immunoprecipitated with 30 µL of Sepharose-A beads (GE Healthcare) for 30 
minutes at 4°C with rocking. Following the incubation, lysates were washed twice 
with RIPA + 0.30 M NaCl, twice with RIPA + 0.15 M NaCl, and once with SDS 
wash II (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 2.5 mM EDTA). 30µL of 2X SDS 
loading buffer was added to each sample and boiled for 10 minutes. Samples were 
run on 15% SDS-PAGE gels, dried, and exposed to a Phosphor screen for three 
days. The phosphor screens were visualized using the Typhoon imaging system 
(GE Healthcare). To quantify bands for analyses, band densitometry (ImageQuant 
5.2) was used. Total protein expression was determined as the sum of the 
uncleaved F0 plus the cleaved larger F subunit, F1  
Surface biotinylation 
Vero cells were seeded in 60mm dishes to be approximately 80% confluent for the 
next day. The following day, cells were transfected with 4.0 μg of pCAGGS-MCS, 
pCAGGS-PIV5 F WT or pCAGGS-PIV5 F LIZ with lipofectamine plus and plus 
reagent (Thermo Fisher) according to manufacturer’s instruction. At 18-24 hours 
post transfection, cells were washed twice with PBS, and starved for 45 mins in 
cysteine-methionine-deficient DMEM. The cells were then labeled in conditioned 
cysteine-methionine-deficient DMEM containing Tran[35S]-label (100 μCi/ml; MP 
Biomedicals) for three hours. At this time, cells were washed three times in ice-
cold PBS, pH 8, followed by a 35 minute biotinylation with 1mg/mL of EZ-Link 
Sulfo-NHS-Biotin (Pierce) in PBS pH 8 with rocking at 4°C. The cells were then 
brought to room temperature for 15 minutes and washed twice with ice-cold PBS 
pH 8. Cells were lysed in 500 μL of RIPA lysis buffer, scraped, and centrifuged at 
136,500 × g  for 15 mins at 4°C. The supernatant was transferred to a 1.5mL 
Eppendorf tube, where 8 μL of PIV5 F antibody 516-529 were added to incubate 
with rocking for three hours. The fusion protein was then immunoprecipitated by 
incubating with 30 μL of protein Sepharose-A beads (GE Healthcare) for 30 
minutes and washed twice with RIPA + 0.30 M NaCl, twice with RIPA + 




10% SDS was added, and the samples were boiled for 10 min, transferred to a 
separate tube, and washes repeated with 40 μL of 10% SDS for a total of 100 μL. 
10 μL, denoting 10% of the supernatant, was moved to a separate tube to be used 
to analyze the total protein population. To the remaining supernatant, 30 μl of 
streptavidin beads (Pierce) and 400 μl of biotinylation dilution buffer (20 mMTris 
(pH 8), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.2% bovine serum albumin) 
were then added for 1 h at 4°C with rocking. Streptavidin was used to label the 
biotinylated surface population, which was subsequently precipitated and washed 
with RIPA buffers as noted above for the total population. Samples were analyzed 
with 15% SDS-PAGE and visualized using the Typhoon imaging system (GE 
Healthcare). Band densitometry using ImageQuant 5.2 was performed for each 
experiment to quantitate the amount of F expressed, which was calculated as the 
sum of F0 and F1, normalized to WT. (Figure 2.1)  
Surface expression with prefusion conformation-specific antibody: flow 
cytometry 
Subconfluent Vero cells were transfected with pCAGGS-PIV5 F WT or pCAGGS-
F LIZ using Lipofectamine plus and Lipofectamine reagent according to the 
manufacturer’s protocol (Thermo Fisher). Cells were washed twice with ice cold 
PBS twenty-four hours after transfection. The remainder of the experiment was 
performed on ice unless otherwise indicated. After washing, transfected cells were 
incubated with rocking with 1:300 of mAb F1a antibody, which detects the 
prefusion form, for 1 h. Cells were subsequently washed and incubated with a 
FITC-conjugated secondary antibody at 1:1000 for 30 minutes with rocking, away 
from light (covered in tin foil). Cells were once again washed with PBS, lifted with 
50mM EDTA in PBS for 15-20 minutes at 37ºC and then transferred to 4ºC for 3 
hours. Following lifting, cells were fixed at in 2% PBS and transferred to FACS 
tubes for processing at the UK flow cytometry core.  
Syncytia assay 
Subconfluent BHK cells in a 6 well plate were transfected with pCAGGS-PIV5 F 
WT or pCAGGS PIV5 F LIZ and pCAGGS-PIV5 HN in a ratio of 1:1 for PIV5 F:PIV5 




TS100 microscope with 10× objective. Syncytia were captured with a Nikon digital 
camera attached to the microscope. 
Luciferase reporter gene assay 
Subconfluent Vero cell monolayers in 12-well plates were transfected with T7 
promoted Luciferase plasmid, pCAGGS-PIV5 F WT or LIZ, and pCAGGS-PIV5 
HN. Transfection was performed at 1:1:0.8 for F:HN:luciferase under T7 promoter. 
At 24 hours post-transfection, BSR T7 cells expressing the T7 RNA polymerase 
were overlaid onto the Vero cells and incubated at 37°C for 3 hours. The 
monolayers were then washed twice with PBS, lysed in a luciferase lysis buffer 
(Promega), and clarified by centrifugation per the manufacturer's instructions 
(Promega). For each sample, lysate was loaded into a 96-well plate, where 
luciferin was added at a 1:1 ratio of lysate:luciferin. Where there was successful 
fusion, T7 RNA polymerase from BSR cells would gain access to and synthesize 
the Luciferase mRNA under the control of the T7 promoter. Luciferase enzyme 
activity was quantified in a luciferin-dependent reaction and quantified as 
luminescence with a Lmax luminometer (Molecular Devices). Luciferase reporter 
activity for mutants were normalized to WT. (Figure 2.2) 
Thermal triggering assay 
Subconfluent Vero cells in a 12 well plate were transfected with either pCAGGS-
PIV5 F WT of LIZ according to manufacturer’s protocol (Lipofectmaine plus and 
lipofectamine reagent; Thermo Fisher). The following day, at 24 hours post 
transfection, transfected Vero cells were utilized in a thermal triggering assay as 
follows: for 15 minutes, cells were incubated at 4ºC, 37ºC, 55ºC, 60ºC, and 65ºC. 
Cells were immediately placed on ice after thermal treatment for 15 minutes to halt 
triggering, before they were prepared for flow cytometry. The rest of the procedure 
was performed on ice as detailed above in the flow cytometry protocol used to 
quantify surface expression of the prefusion F. The thermal triggering assay 
addressed changes in expression of the prefusion conformation of F at the surface 





HMPV matrix protein project 
 
Cell lines and culture 
A549, BEAS-2B, and Vero cells were acquired from ATCC. A549 cells were 
maintained in F-12 (Kaighn’s) medium (GE Healthcare), supplemented with 10% 
FBS (Sigma) and 1% penicillin/streptomycin. BEAS-2B cells were grown in 
bronchial epithelial cell growth medium (BEBM) supplemented with the reagents 
from a BEGM SingleQuot kit growth factors (Lonza), and Vero cells were 
maintained in DMEM supplemented with 10% FBS (Sigma). BSR cells were a kind 
gift from Karl-Klaus Conzelmann (Max Pettenkofer Institute) and were maintained 
in Dulbecco’s modified Eagle’s media (DMEM) and 10% FBS. 
Plasmids and antibodies 
Mutants for the study were created using the QuikChange site-directed 
mutagenesis kit (Stratagene) in pGEM, and subcloned into the eukaryotic 
expression vector pCAGGS [119], for expression in A549 and Vero cells. pTM1 L, 
M2-1, N, P and CAT-Luciferase minigenome reporter assay plasmids for HMPV 
were a kind gift from Dr. Rachel Fearns (Boston University). For all the transfection 
analyses, lipofectamine 3000 (Thermo Fisher) was used per manufacturer’s 
instructions. All constructs used were sequenced (ACGT) to ensure sequence 
integrity. We used the conformational antibody mAb JOJ (obtained from Thermo 
Fisher) for immunofluorescence experiments and conformational studies, and a 
polyclonal against antibody avian metapneumovirus M protein, which also cross-
reacts with HMPV M, kindly provided by Sagar M. Goyal (University of Minnesota), 
for Western blotting and radioimmunolabeling. HMPV N antibodies were obtained 
from Abcam, HMPV F 54G10 antibody was a kind gift from Dr. John Williams 
(University of Pittsburgh).  
FISH probe design 
Forty-eight fluorescence in situ hybridization (FISH) probes that target the HMPV 
RNA sequence between nt 1 and 5467, which contain the genes for N, P, M, F, 




was 20 nt long and linked at the 3’ end to the Quasar 570 fluorophore for probes 
complementary to vRNA [120]. 
PPMO design  
Peptide-conjugated phosphorodiamidate Morpholino oligomers (PPMO) were 
designed to target and knockdown the HMPV matrix protein. The PPMO was 
designed based on the several strains of HMPV, and ultimately, the HMPV strain 
CAN97-83 strain used in this study. The 25 nucleotide (nt) PPMO sequence was 
designed to encompass 13 nts upstream of the AUG start sequence in the 5’UTR, 
and span the first 12 nts of the matrix protein nucleotide sequence. 
Phosphorodiamidate Morpholino oligomers (PMO) were obtained from Gene-
Tools. An arginine-rich peptide was added to PMOs to create PPMO by Hong 
Moulton and David Stein (Oregon State University). The peptide is a potent aid in 
cellular delivery of PPMO [121-123]. 
Viral propagation 
WT HMPV strain CAN97-83, generously provided by of Guy Boivin (Université 
Laval, Canada) and recombinant, GFP-expressing HMPV (rgHMPV) strain 
CAN97-83 (a kind gift of Peter Collins and Ursula Buchholz, National Institutes of 
Health) were propagated in Vero cells. WT HMPV and rgHMPV were propagated 
at a starting multiplicity of infection (MOI) of 0.01, and incubated at 32°C with Opti-
MEM, 200 mM L-glutamine, and 0.3 μg/ml tosylsulfonyl phenylalanyl chloromethyl 
ketone (TPCK)-trypsin, which was replenished every day. On days 7-9, cells were 
scraped and collected in 1X SPG (218mM Sucrose, 4.9 mM L-glutamic acid, 3.8 
mM KH2PO4, 7.2 mM K2HPO4) and frozen at −80°C. The cells were then thawed 
at 37 °C and subjected to a total of three freeze/thaw cycles before centrifugation 
at 2,500 × g for 20 minutes at 4°C on a Sorval RT7 tabletop centrifuge to clear 
cellular debris. The supernatant was then centrifuged on a 20% sucrose cushion 
in TNE (50 mM Tris-HCL, pH 7.4, 100mM NaCl, 0.1mM EDTA) for 2 h and 30 
minutes at 27,000 × g and 4°C using a SW28 swinging-bucket rotor on a Beckman 
Optima L90-K ultracentrifuge. Following centrifugation, the supernatant was 




incubated at 4°C overnight with rocking to resuspend the viral particles. Samples 
were aliquoted, flash frozen and stored at −80°C.  
Recombinant GFP-expressing PIV5, a kind gift from Robert Lamb (Howard 
Hughes Medical Institute, Northwestern University) and Jessica Robach 
(Northwestern University) was grown in MDCK cells. RSV A2 expressing GFP 
(rgRSV) was kindly gifted by Medimmune/Astrazeneca. For propagation, an MOI 
of 0.1 of rgRSV was added to Hep-2 cells in Opti-MEM. After 3 h incubation, Opti-
MEM with 2 mM L-glutamine was added and cells were incubated for 4 to 5 days 
at 37 ºC. Cells were then scraped and treated with one freeze-thaw cycle. Cell 
debris was spun down at 2500rpm and the supernatant made up to 1X of sucrose 
phosphate (Hyclone, special order from Astrazeneca/Medimmune). Samples were 
aliquoted and flash frozen to be kept at −80°C. Viral titers were determined by 
performing serial dilutions and infecting Vero cells in a 96 well plate. The number 
of fluorescent cells were counted at 24 h.p.i to determine number of plaque forming 
units that were present per mL (pfu/mL). 
Time course immunofluorescence assay 
Ten mm coverslips were coated with 1 mg/mL of bovine serum albumin, 10 µg/mL 
of fibronectin, and 30 µg/mL of collagen in BEBM at 37°C overnight. The following 
day, the coating was aspirated, and BEAS-2B cells were seeded on coated 
coverslips to be between 65 – 75% confluency by the next day. Infection was 
carried out as follows: starting with a multiplicity of infection (MOI) of 4, cells were 
inoculated with WT HMPV in Opti-MEM. Cells were immediately incubated at 4°C 
for 2.5 hours to synchronize infection. After this, the inoculum was removed and 
replaced with fresh Opti-MEM and cells were immediately incubated at 37°C. The 
time of media replacement and 37°C incubation denotes 0 hours post-infection 
(h.p.i). Following infection, cells were rinsed twice with PBS and fixed in 4% PFA 
for 20 minutes at indicated times post-infection. After fixing, cells were washed 
three times with PBS and incubated for 15 minutes with permeabilization buffer 
(1% Triton-X-100 in PBS) at 4°C. Cells were subsequently washed twice in PBS, 




the JOJ anti HMPV M monoclonal antibody at 1:100 in 1% NGS overnight at 4°C. 
Cells were then washed seven times with 0.05% Tween 20 in PBS, and incubated 
with a TRITC-conjugated secondary antibody at 1:300 in 1% NGS for 1 hour at 
4°C. The cells were washed again seven times with 0.05% Tween 20 in PBS, 
before being mounted with VECTASHIELD antifade mounting media with DAPI 
(Vectorlabs). Images were taken using a Nikon A1 confocal microscope and 
analyzed with NIS-Elements software. Images were processed with Adobe 
Photoshop with equivalent adjustments made to all channels. 
HMPV minigenome luciferase assay 
BSR cells expressing T7 polymerase were transfected with pCITE-HMPV N, 
pCITE-HMPV P, pCITE-L, pCITE-M2-1, and a minigenome reporter cassette that 
encodes a luciferase reporter minigenome construct under control of the T7 
promoter using the lipofectamine 3000 system per manufacturers instruction. The 
amounts transfected are as follows: minigenome: 1.2 µg; P: 0.12 µg; N 0.12 µg, 
M2-1 0.1 µg. For these conditions, an increasing amount of M, up to 2.0 µg was 
added to observe effects on minigenome reporter activity. For each condition, the 
total amount of DNA transfected was kept constant by making up the difference 
with empty pCAGGS. At 24 hrs post-transfection, cells were lysed in a luciferase 
lysis buffer and clarified by centrifugation per the manufacturer's instructions 
(Promega). For each sample, lysate was loaded into a 96-well plate, where 
luciferin was added at a 1:1 ratio of lysate:luciferin. In this case, reporter activity is 
read out as the luminescence of enzyme produced with luciferase mRNA is 
produced by the minigenome, and the effect of increasing amounts of M on 
luciferase activity is measured (Figure 2.4). 
Infected cell count after PPMO treatment 
Subconfluent Vero cells in 6-well plates were infected with HMPV at an MOI of 4. 
The process of infection is described above. At times indicated post-infection, a 
final concentration of 5µM of either scrambled (control) PPMO or HMPV M-specific 
PPMO diluted in Opti-MEM were added to cells. At 24 hrs post-infection, cells were 




FACS tubes, where samples were made up to 2% PFA in solution with EDTA and 
PBS. Samples were analyzed using flow cytometry to determine viral titer as a 
result of adding PPMO. 
Cell toxicity assay 
Vero cells were seeded in a 96 well plate. The next day, two-fold serial dilutions of 
control or HMPV M-specific PPMO were made in Opti-MEM and added to cells. At 
24 hours post-treatment, propidium iodide (Thermo Fisher) was subsequently 
added to quantify the ratios of cell death in PPMO-treated samples compared to 
untreated samples. Live cells were counted using flow cytometry as a percentage 
of the total population (live and dead cells) at the UK flow cytometry core. 
Immunofluorescence with fluorescence in situ hybridization (FISH)  
Subconfluent A549 and BEAS-2B cells grown on 10mm coverslips were infected 
with WT HMPV as described above. At 0 h.p.i., cells were treated with control or 
M-specific PPMO as earlier detailed. Cells were then fixed for immunofluorescence 
in the protocol detailed above, except FISH was performed before cells were 
mounted. After the final washes following incubation with the secondary antibody 
for the immunofluorescence portion, cells were once again fixed in 4% PFA for 15 
minutes at room temperature. After fixing, cells were washed twice with PBS, and 
once with 2x SSC-10% formamide buffer, and then transferred to a humidified 
chamber, where they were incubated overnight at 25°C in FISH vRNA probes 
diluted at 1:100 in hybridization buffer (4x SSC, 1x Denhardt’s solution, 150 µg/mL 
ssDNA, 2mM EDTA, 50% formamide in DEPC treated water). After 24 hours, cells 
were washed two times for 20 minutes per wash with 2x SSC-10% formamide 
buffer and coverslips were mounted using VECTASHIELD antifade mounting 
media with DAPI (Vectorlabs). Images were taken using a Nikon A1 confocal 
microscope and analyzed with NIS-Elements software. Images were processed 
with Adobe Photoshop with equivalent adjustments made to all channels. 
RNA extraction and quantitative real time PCR 
A549 cells were grown in 6-well plates overnight until a 75-85% confluency was 




PPMO at indicated times post infection. At the indicated times post infection, the cells 
were washed twice with PBS and then lysed with 500 μl of TriPure isolation reagent 
(Sigma). The total RNA was extracted according to the manufacturer's instructions. 
RNA was immediately treated with amplification-grade DNase I (Sigma) for 15 min at 
room temperature, followed by inactivation at 70°C for 10 min. Reverse transcription 
was performed starting with 500 ng of DNase-treated RNA, 1.25 mM deoxynucleoside 
triphosphates, 10 U avian myeloblastosis virus reverse transcriptase (Promega), and 
1.25 μM of indicated primers listed in table 2.1. The reaction mixtures were incubated 
at 80°C for 10 min and then at 42°C for 60 min. For quantitative PCR, 2 μl of freshly 
made cDNA from the reverse transcription described above was mixed with 1.25 μM 
each specific primer, Perfecta SYBR green Supermix, and low-carboxy-X-rhodamine 
reagent (Quanta Biosciences) according to the manufacturer's instructions. The 
assays were performed using a stratagene Mx 3005P system (Agilent Technologies). 
The following cycle parameters were used for the experiment: 95°C for 2 min and 40 
cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 60 s. The results were normalized 
to the average level of expression of the housekeeping gene control, glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) and tubulin. 
Protein expression studies 
Detecting viral proteins in HMPV infection in response to PPMO treatment: 
Subconfluent A549 cells were infected with rgHMPV or WT HMPV, followed by 
PPMO treatment at 0 h.p.i. as described above. 1.5 hours before indicated time 
points, cells were rinsed twice with PBS and starved with cysteine-methionine-
deficient media for 30 minutes at 37ºC. Following the starve, cells were labeled 
with Tran[35S] metabolic label (100 μCi/mL; MP Biomedicals) for 1 hour. Following 
the label, the cells were washed three times with PBS and lysed with 
radioimmunoprecipitation (RIPA) lysis buffer, and radioimmunoprecipitation was 
performed as described in the PIV5 F methods section. 
Detecting HMPV M calcium coordinating residue mutants: Subconfluent A549 
cells were transfected with pCAGGS-HMPV M using Lipofectamine 3000 
according to the manufacturer’s protocol. HMPV M expression (WT and mutants) 




Western blotting the total lysate. For Western blots, cell lysates were run on 15% 
SDS PAGE gels, and transferred to polyvinylidene difluoride (PVDF) membranes 
(Fisher) at 50 V for 80 min at 4°C. Membranes were subsequently blocked with 
5% milk in Tris buffered saline with 0.05% Tween-20 (TBS-T). Then, membranes 
were incubated with anti-AMPV M antibody in 5% milk TBS-T. Membranes were 
washed with TBS-T and incubated with anti-rabbit secondary antibody at 1:10,000 
(Jackson). Membranes were washed again with TBS-T and visualized with the 
LiCor imaging system. 
 
Statistical analyses 
The average value and standard deviation from each indicated experiment were 
computed. Analyses were generally performed using a two-way ANOVA for 
multiple comparisons, or the Student t test for pairwise comparisons. p values are 
indicated for each individual experiment. All statistical analyses were performed 





Table 2.1 List of primers used for qPCR experiments.  
 
Target Primer 
RT/HMPV vRNA AACGCGTATAAATTAAGTTAC 
qPCR/HMPV Pvm/F ACCTACCAAACCGACCATATTG 
qPCR/HMPV Pvm/R CTTCAGTTTTGATTGCCCCAC 
qPCR/hmpv N m/F GTGCTGGTCAAACAATGCTG 
qPCR/hmpv N m/R ACTCAGCTTGGACAGATACATG 
qPCR/hmpv M m/F CTATCAAGGAGAGTGAATCAGCC 
qPCR/hmpv M m/R GATCAGTCCCGCATAAGGTG 
qPCR/hmpv F m/F GAGAACATTGAAAACAGCCAGG 
qPCR/hmpv F m/R AGAGCCAAGGACAGCAATTAG 
qPCR/hmpv M2-1 m/F GCCTGCTACAGTCTACACAAC 
qPCR/hmpv M2-1 m/R AGATGCGGGAGTTTTGCTC 
qPCR/hmpv M2-2 m/F TGACTCTTCATATGCCCTGC 
qPCR/hmpv M2-2 m/R GAGACTTCACTATCCCATCGG 
qPCR/hmpv SH m/F AGACTCACCATCAAATACCACATC 
qPCR/hmpv SH m/R TTATTTTCCAGCATGTGTCCTTG 
qPCR/hmpv G m/F TCACAGCATCCAACTCAACAG 
qPCR/hmpv G m/R TGCTGGTTCTGTTTCTGATGG 
qPCR/hmpv L m/F GCAAGTTCAACCAAGCCTTTAG 
qPCR/hmpv L m/R GTGTTCCATGTAATTCGTCTGC 
Oligo(dT)20 TTT TTT TTT TTT TTT TTT TT 
 






Figure 2.1. Workflow of the surface biotinylation protocol.  
Cells are transfected with pCAGGS-PIV5 F and incubated overnight. Cells are then 




methionine. Following the radioactive label, the surface population of cells is also 
labeled with biotin before cell lysis and lysate clarification. F proteins are 
immunoprecipitated, and at this point 10% is reserved to be analyzed as “total 
protein”. The remaining 90% is incubated with streptavidin to distinguish surface-
expressed F only. The surface protein is boiled to be released from beads, run on 






Figure 2.2. Schematic representation of luciferase reporter fusion assay.  
BSR cells constitutively expressing T7 polymerase were overlaid onto Vero cells 
transiently expressing PIV5 F (WT or LIZ), PIV5 HN, and containing plasmids with 
luciferase under a T7 promoter. Where PIV5 F is functional, F would merge the 
membranes of BSR and Vero cells, giving the T7 polymerase access to the 
luciferase in Vero cells under the T7 promoter. Thus, if fusion occurs, luciferase is 
synthesized. The readout of fusogenic activity is observed from the reaction of 
luciferin in the cell lysates reacting with luciferin. The reaction produces 








Figure 2.3. Principle of thermal triggering assay.  
To test the thermostability of the PIV5 F WT or LIZ, cells transfected with either 
construct is subject to heat treatment at indicated temperatures for 15 minutes. If 
the protein remains in the prefusion conformation, mAb F1a, the prefusion antibody 
will still bind, thus secondary antibodies bound can be quantified by flow cytometry. 
The lack of mAb F1a binding is a direct function of the amount of F that is triggered 








Figure 2.4. Schematic of the minireplicon system mechanism. 
BSR cells constitutively expressing T7 polymerase are transfected with a positive 
sense luciferase minigenome under a T7 promoter, along with the viral 
components required for viral replication: N, P, L, and M2-1. Once the minigenome 
is delivered, T7 polymerase from BSR cells gains access to the +strand 
minigenome, and makes a negative sense RNA copy. At the same time, N,P,L, 
and M2-1 that are freshly synthesized in the transfected cell can access and read 




into luciferase mRNA. This mRNA is translated into luciferase protein. The -luc 
RNA genome is also used as a template for replication: it also directs formation of 
+luciferase RNA, which is in turn used to generate more -luciferase template for 
mRNA and protein production. Lysates from this when incubated with luciferin 
produce varying degrees of luminescence, as a direct readout of the efficiency of 
viral elements to support replication and transcription. In this assay, increasing 
amounts of M was added to examine its effect on baseline transcription and 








Chapter 3 : PARAINFLUENZA VIRUS 5 FUSION PROTEIN 
MAINTAINS PREFUSION STABILITY BUT NOT FUSOGENIC 
ACTIVITY FOLLOWING MUTATION OF A TRANSMEMBRANE 
LEUCINE/ISOLEUCINE DOMAIN 
 
Portions of this chapter were adapted and reprinted with permission from the 
Microbiology Society: Branttie JM, Dutch RE. Parainfluenza virus 5 fusion protein 
maintains pre-fusion stability but not fusogenic activity following mutation of a 
transmembrane leucine/isoleucine domain. J Gen Virol. 2020 May;101(5):467-
472. doi: 10.1099/jgv.0.001399. Epub 2020 Feb 25. PMID: 32100701; PMCID: 
PMC7414451. 
Introduction 
Parainfluenza virus 5 (PIV5), measles virus (MeV), and the zoonotic Hendra 
virus (HeV) and Nipah virus (NiV), are enveloped viruses that belong to the family 
Paramyxoviridae [124]. MeV, HeV, and NiV are highly pathogenic viruses of 
worldwide significance [125], while PIV5 serves as an important Paramyxoviridae 
viral model system [126]. Although there are vaccines against MeV and its rampant 
spread has been mainly checked, there is still a troubling proportion of the global 
population that remains unvaccinated [127]. In fact, lack of MeV vaccination is the 
leading worldwide cause of preventable deaths in children. For these unvaccinated 
groups, MeV causes a range of symptoms, with one of the deadliest being 
encephalitis [128]. HeV and NiV similarly can result in encephalitis upon disease 
onset, but patients may also have repeated cases of encephalitis following initial 
recovery [129]. A combination of HeV and NiV being bat-borne, the high morbidity 
and mortality rate, along with the lack of human vaccines or therapeutics [130, 
131], make apparent the potential risk of a global henipavirus pandemic. Moreover, 
the voluntary lack of vaccinations against MeV potentially poses a threat to herd 
immunity, particularly putting immunocompromised individuals at risk. These 
observations highlight the need for basic and clinical research in paramyxoviruses 




Paramyxoviruses contain a non-segmented negative sense (NNS) RNA 
genome. Within the paramyxovirus family, virion structures are generally highly 
pleomorphic in size and shape [125, 132, 133]. In contrast, cryo-electron 
microscopy has demonstrated that PIV5 particles are mostly spherical [133], 
similar to Sendai virus (SeV) particles [132]. Paramyxovirus particles range from 
between 110 and 540nm in size, with some particles bearing more than one copy 
of the viral genome [125, 132]. Data also shows that when compared to other 
negative sense RNA viruses such as Influenza and Marburg viruses, the genomic 
packaging of SeV appears to be less ordered, in some cases forming a “tangled 
knot” [132]. For paramyxoviruses, the RNA copies are encased in nucleoprotein 
(N) and are associated with the phosphoprotein (P), which is a polymerase 
cofactor, and a large RNA dependent RNA polymerase protein (L) also forming 
part of the RNP. Altogether, the viral RNA and its encapsidated proteins form 
helical ribonucleocapsid filaments, further protected by a viral glycoprotein-rich 
double layered membrane. The two most prominent glycoproteins within the family 
are the attachment protein (G/HN/N) and the fusion protein (F), which is largely 
responsible for successful entry of viral particles to host cells. The PIV5 attachment 
protein is denoted by HN for its hemagglutinin neuraminidase activity  [134].  
For these enveloped viruses, successful infection requires fusion of their 
membranes with target cell membranes to allow for content mixing [41, 53]. Since 
membrane fusion is energetically costly [135] , F and G/HN/H serve as critical viral 
surface proteins that lower the kinetic barrier to drive the fusion and entry process. 
The fusion proteins of PIV5 and other paramyxoviruses are folded into 
homotrimers within the endoplasmic reticulum (ER) as they are synthesized. 
These proteins contain a fusion peptide (FP), heptad repeats A and B, the 
transmembrane domain (TMD) and a cytoplasmic tail. For fusion to occur, the 
attachment protein tethers the viral particle to the host cell via interactions with 
cellular receptors; subsequently, the F protein drives the fusion process by 
undergoing large-scale, essentially irreversible conformational changes from a 
metastable pre-fusion structure to a highly stable post-fusion conformation that 




conformational changes entail the unraveling of the HRA and FP from the 
ectodomain head and movement of these regions towards the target cell, where 
the FP is initially inserted to form a pre-hairpin intermediate. As this state is less 
energetically favorable, the protein then refolds into a low energy conformation, 
creating a six-helix bundle of the HRA and HRB domains, and merging the two 
membranes to create a fusion pore [53]. This fusion pore must expand before viral 
RNA can pass into the host cell, with expansion postulated to be mediated in part 
by the cytoplasmic tail (CT) of the paramyxovirus fusion protein [136]. 
Like other class I fusion proteins, paramyxovirus F proteins are synthesized 
in a metastable prefusion state and folded in ER into the homotrimer that must be 
proteolytically cleaved to become fusogenically active [135]. The cleavage event 
unveils a FP that interacts with the target membrane to facilitate the 
aforementioned fusion process [137, 138]. Upon synthesis, the HeV F is trafficked 
through the secretory pathway to be expressed on the cell surface in its 
fusogenically inactive form (F0). Subsequently, HeV F0 is endocytosed and cleaved 
by the protease cathepsin L within endosomes and retrafficked to the surface in a 
disulfide-linked fusogenically active form (F1 +F2) [41, 139]. Conversely, PIV5 F 
trafficking is more straightforward: it is similarly synthesized in the secretory 
pathway, but undergoes cleavage within the trans-Golgi network (TGN) by furin 
during transport to the cell surface to be expressed as F1 + F2 [41, 44, 134, 139, 
140]. Importantly, throughout the trafficking process, paramyxovirus F proteins 
must be maintained in a metastable pre-fusion state, as premature triggering 
renders the protein fusion inactive [74]. 
Although certain paramyxovirus F proteins such as SeV F can trigger in the 
absence of their homotypic attachment proteins [141], most paramyxoviruses 
engage in complex interactions with their attachment proteins to begin refolding 
from the pre-fusion to the post-fusion state [134, 142]. Indeed, the triggering of 
fusion by initiation of conformational changes still presents as a significant gap in 
our knowledge fusion regulation. A number of studies have focused on how 




focus on possible interactions with the attachment protein in transmitting 
conformational changes after attachment to signal the F protein to trigger. [53, 143, 
144]. Interestingly, an unsuspected player, the transmembrane domain (TMD), 
which was initially thought to mainly serve as a membrane anchor, has recently 
been shown to play critical roles in the pre-fusion stability of the paramyxovirus F 
proteins [41, 74, 145-149]. In isolation, the TMDs of HeV F, PIV5 F and the closely 
related pneumovirus human metapneumovirus (HMPV) F self-associate in trimers. 
For HeV F, an AXXXG motif, similar to the GXXXG motif known to support 
association of hydrophobic residues, was found to be important for maintaining 
surface levels of the cleaved prefusion form [41]. On further investigation, another 
important association motif, the leucine/isoleucine (L/I) zipper was identified in the 
TMD of HeV F and similar β-branched residues in heptad repeats were found for 
140 other paramyxoviruses, including PIV5 F. Studies on HeV F showed that not 
only is the L/I zipper important for the self-association of the TMDs in isolation, but 
it is also important in the pre-fusion stability of the full HeV F protein, and 
circumvents premature triggering and misfolding. These studies showed a severe 
reduction in surface and total expression for the HeV L/I zipper mutants, termed 
LIZ mutants. Not surprisingly, HeV F LIZ mutants are also deficient in forming 
syncytia, a consequence of not being stably present on the cell surface ([74, 145, 
146]. 
This exciting finding of a potential TMD target that could abrogate viral infection 
led our group to probe the extent to which the L/I zipper drives fusogenic activity 
in other closely related viruses. To examine this, we used PIV5, a model 
paramyxovirus. We introduced alanine mutations to the L/I zipper of PIV5 F to 
create a PIV5 F LIZ mutant. Our data show that the PIV5 LIZ mutant is expressed 
on the surface and total levels in similar ways to WT. Surprisingly, despite the 
relative abundance of potentially fusogenically active pre-fusion PIV5 F LIZ on the 
surface of transfected cells, there is a considerable decrease in the functionality of 
the fusion protein, suggesting that the L/I zipper is a potentially relevant target in 





HeV F LIZ and PIV5 F LIZ localize differently from WT 
Understanding the roles of the transmembrane domain in facilitating 
functional activities of the fusion protein requires extensive study of its oligomeric 
associations. Recently, SAXS and solid state NMR data have corroborated studies 
from the Dutch lab that PIV5 F TMD associates in a trimer [41, 74, 145, 148]. Our 
lab has shown that for HeV F, these trimeric associations are at least in part 
supported by the hydrophobic interactions mediated by the heptad repeat L/I 
zipper [74]. Given these observations, we were interested in whether LIZ mutations 
affected the placement of the fusion protein of HeV in transfected cells. Surface 
expression of the fusion protein is important in orienting it for proper assembly into 
viral particles and for positioning for syncytia formation. Additionally, we were 
interested in the role of the TM L/I zipper motif in paramyxovirus F proteins to 
examine whether the L/I zipper functionality observed in HeV F is conserved 
across the family. To address these questions, we introduced TM L/I zipper alanine 
mutations to create PIV5 F LIZ (Figure 3.1). With this mutant, we performed 
immunofluorescence on cells to analyze the intracellular localization compared to 
PIV5 F WT.  Our results demonstrate that while HeV F WT displays a ubiquitous 
cellular distribution, HeV F LIZ is mostly confined in pockets around the nucleus 
consistent with the placement endoplasmic reticulum (Figure 3.2 A). These 
observations corroborate previous data that showed that surface and total 
expression of HeV F LIZ was considerably lower than for HeV F WT [74].  
 
Interestingly, we found that PIV5 F WT primarily localizes at the surface of 
the cell and is present within membrane ruffles, while PIV5 F LIZ shows a higher 
level of intracellular distribution. We further examined multiple focal planes of cells 
transfected with PIV5 F WT and LIZ using Z-stacks (Figure 3.2 B). We found that 
PIV5 F WT is mostly absent from the immediate perinuclear region in different 
optical slices, but PIV5 F LIZ is distributed more evenly throughout the cells and is 
present in puncta close to the nucleus. These results suggest a more subtle yet 




of the protein. Likewise, these data indicate a more modest effect of the TM L/I 
zipper in protein folding for PIV5 F than for HeV F. 
PIV5 F LIZ is expressed comparably to PIV5 F WT in time course 
Our data showed that not only was HeV F trafficking impaired, but levels of 
expression were dramatically affected by the L/I zipper [74]. Sustained expression 
and stability of the fusion protein is paramount to its biological activity and could 
affect the ability of the full viral particle to be infectious over longer periods of time. 
We were interested in whether the role of the L/I zipper in stable HeV F expression 
is preserved across the paramyxovirus family. If paramyxovirus fusion proteins 
need TMD L/I zipper interactions to be stably maintained in their pre-fusion form 
during infection, their removal would reduce the lifespan of the fusion protein. 
Therefore, to biochemically assess the effect of the L/I zipper on PIV5 F synthesis 
and stability, we performed a pulse-chase time course assay, using PIV5 
cytoplasmic tail antibody 516–529, to examine PIV5 F WT and PIV5 F LIZ stability 
(Fig. 3.3). Previous studies showed that total expression over time for HeV F LIZ 
was significantly decreased compared to WT [74]. Surprisingly, between 0 and 8 h, 
PIV5 F LIZ expression was comparable to WT, suggesting that the PIV5 F L/I 
zipper is not critical for stability, unlike the L/I zipper of HeV F [74]. This observation 
indicates that the L/I zipper is not critical for all paramyxovirus fusion protein 
stability. 
Surface expression of pre- and post-fusion PIV5 F is moderately affected 
by the L/I zipper 
Since the presence of F at the membrane is crucial for biological activity, 
we probed the surface expression of PIV5 F WT and LIZ in transfected cells using 
a surface biotinylation assay. We found that after radiolabeling newly synthesized 
F protein for 3 h with S35 at 18–24 h post-transfection, PIV5 F LIZ surface 
expression is decreased by more than 30 % when compared to WT. In contrast, 
total amounts of protein between PIV5 F WT and LIZ remain comparable (Figure 
3.3 A and B). The antibody, anti PIV5 F 516–529, that was used in this experiment 
is able to detect both pre-and post-fusion forms of the protein, indicating that the 




surface than for PIV5 F LIZ. From these findings, we conclude that L/I zipper 
interactions do not significantly affect the overall sum of protein expressed; 
however, taken with Figure 3.2, the data show that the PIV LIZ mutant shows some 
redistribution throughout the cell compared to the PIV5 F WT. Surprisingly, PIV5 F 
LIZ mutations displayed a slightly higher cleavage ratio for surface expressed F 
than for WT. This may be a result of increased intracellular localization because of 
the LIZ mutations, as longer retention of PIV5 F LIZ within the TGN would provide 
extended exposure to the cleavage protease furin before the F protein is finally 
transported to the cell surface. 
The L/I zipper mutations ablate fusogenic activity of the fusion protein 
While data shown in Figure 3.4 show that PIV5 F WT and LIZ are expressed 
at comparable levels at the cell surface, we were interested in selectively 
quantifying the population of potentially fusogenically active protein at the surface. 
We performed flow cytometry with the pre-fusion-specific PIV5 F mAb F1a. These 
data also show that the pre-fusion form of PIV5 F LIZ is only slightly lower than for 
PIV5 F WT (Figure 3.5). This suggests that although there is a slight decrease in 
metastable, pre-triggered PIV5 LIZ F on the surface of cells, there is still a 
significant presence of potentially fusogenically active PIV5 at the surface of cells 
in the absence of the L/I zipper. 
 
Having established that pre-fusion PIV5 F LIZ can still be trafficked to the 
surface of cells, we utilized a syncytia assay to test the fusogenic activity of PIV5 
F LIZ in comparison to WT. When expressed with its homotypic attachment 
protein, PIV5 F can form syncytia in vitro. We used this model to examine 
functionality of the PIV5 F LIZ mutant in comparison to WT. We observed that PIV5 
F WT is highly fusogenic, as the expression of PIV5 F WT with HN resulted in BHK 
cells fusing into a few, very large syncytia. Remarkably, syncytial activity was 
abolished in the PIV5 F LIZ mutant (Figure 3.6 A). Further characterization of 
fusogenic activity using a luciferase reporter system also showed quantitatively 
that the PIV5 F TM L/I zipper is critical for fusion (Figure 3.6 B). Notably, a leucine 




activity. L486 was shown to be critical for both membrane mixing and content 
mixing, thus identifying L486 as essential in the events leading up to the merge of 
lipid bilayers driven by F [147]. L486 is present in the proposed L/I zipper of PIV5 
F, corroborating this finding in the context of the L/I zipper. 
PIV5 F LIZ mutants are triggered more readily at 55 and 60 ºC 
The comparable PIV5 F WT and LIZ pre-fusion surface expression levels, 
in contrast to the dramatic decrease in HeV F LIZ versus HeV F WT, show that L/I 
zippers in the TMDs of HeV F and PIV5 F play distinct but critical roles in 
maintaining biological activity. While these studies suggest that fusion, rather than 
surface or total expression, is significantly affected by residues within the PIV5 F 
TM L/I zipper, the exact mechanism by which these LIZ mutations abrogate fusion 
is currently unknown. To understand whether PIV5 F LIZ is capable of being 
triggered from its pre-fusion form to undergo the conformational changes that are 
critical for membrane fusion, we transfected cells with either PIV5 F WT or PIV5 F 
LIZ for a thermal triggering assay.  
 
Previous studies show that PIV5 F can be triggered in the absence of its 
cognate attachment protein when exposed to heat [144, 150]. Thus, PIV5 F WT- 
and LIZ-expressing cells were exposed to increasing temperatures (Figure 3.7), 
and flow cytometry using the pre-fusion-specific mAb PIV5 F1a was utilized to 
quantitate the levels of pre-fusion F. Triggering of conformational changes in 
response to heat would lead to loss of F1a binding. Our results show that as the 
temperature increased, the detected levels of pre-fusion F decreased for both the 
WT and LIZ F proteins. Interestingly, at 55 and 60°C, a statistically significant 
increase in the triggering of PIV5 F LIZ compared to WT was observed, potentially 
indicating a role for the TM L/I zipper in stabilizing PIV5 F in the pre-fusion 
conformation. This stabilization is less dramatic than was observed for HeV F [74], 
but does suggest that a role for the LIZ in pre-fusion stability may be a property 
across the viral family. However, it is unlikely that this small decline in the 
thermostability of pre-fusion PIV5 F LIZ would fully account for the drastic loss of 






 A number of studies map out the conformational changes that 
paramyxovirus fusion proteins undergo once triggered [41, 45, 53, 136, 140, 144, 
147, 150-152]. However, there is still a gap in our knowledge of what supports the 
maintenance of the pre-fusion conformation in a metastable, less energetically 
favorable conformation than the post-fusion structure until the appropriate window 
for fusion opens. Our studies sought to understand the relevance of a TMD L/I 
zipper, an association motif found to be important in stability, expression, and 
functionality of HeV F [41, 74, 145], in stabilizing the fusion protein for proper 
function across the paramyxovirus family. We performed mutagenesis of the L/I 
zipper of PIV5 F and probed whether the TMD L/I zipper potentially affected 
stability of this second paramyxovirus protein. Our examination into L/I zipper 
potentially affecting protein stability involved two questions:  
1. Does the L/I zipper affect fusion protein turnover for PIV5 F?; and 
 2. Do mutations in the L/I zipper confer changes to readiness of F to be triggered?  
Our results demonstrate that there is no significant difference in the protein 
turnover of the PIV5 F protein once LIZ mutations were made (Figure 3.2). These 
results are in direct contrast to our previous observation of HeV F [74], highlighting 
a difference in the mechanism of potential function of the L/I zipper within the 
paramyxovirus family. However, our data interestingly showed that for both HeV F 
and PIV5 F, the L/I zipper contribute to F surface expression, albeit to varying 
degrees (Figure 3.2; Figure 3.4; Figure 3.5). Previous studies in our lab have 
implicated the TMDs of paramyxovirses in appropriate trafficking of the fusion 
protein [66, 67]. Although data from HeV F largely suggest that improper trafficking 
results from a higher tendency of the fusion protein to dissociate or misfold [74], 
this current study shows that total amounts of PIV5 F are maintained, and only the 
proportion of protein that is expressed on the surface is reduced for LIZ mutants. 
It is tempting to suggest then, that based on this data and on cumulative data from 




a role in trafficking of the virus to the cell surface. From this study, another 
important parallel in the role of paramyxovirus TMD L/I zippers is drawn: the TMD 
L/I zipper is critical for functionality of the fusion protein for both HeV F and PIV5 
F. In our studies, although there is ample pre-fusion F present at the cell surface 
with the PIV5 F TMD L/I zipper was mutated to alanine, we found that fusion activity 
was ablated (Figure 3.6).  
Reports show that for class I fusion proteins such as Ebola virus GP2, 
influenza virus HA and PIV5 F, the FP and TMDs interact in the post-fusion 
conformation [138, 148, 153, 154]. It is possible that for PIV5 F, the L/I zipper within 
the TMDs contributes to making essential contacts with the fusion peptide to hold 
the post-fusion conformation in place and merge viral and target membranes. 
Additionally, studies demonstrate that the TMs of class I fusion proteins induce 
local membrane changes that decrease the energy barrier needed for fusion [137, 
148, 155] – as such, the L/I zipper of PIV5 F may contribute in this local disruption. 
Finally, it is important to note that PIV5 F is known to make contact with HN through 
an Ig-like domain at the ectodomain [144]. The L/I zipper may be involved in 
transmitting conformational changes that result from this initial contact, and thus in 
refolding. Alternatively, F could have important interactions with HN through 






Figure 3.1. Mutations to the L/I zipper of HeV F and PIV5 F.  
Schematic of the paramyxovirus fusion protein highlighting the TMD L/I zipper of 
HeV F and PIV5 F, and the mutant constructs. FP, fusion peptide; HRA, heptad 
repeat A; HRB, heptad repeat B; TMD, transmembrane domain; CT, cytoplasmic 











Figure 3.2. Immunofluorescence to visualize localization of HeV and PIV5 F 
proteins.  
Vero cells were seeded in eight-well chamber plates and transfected with PIV5 F 
WT or LIZ mutant (left), and HeV F WT or LIZ mutant (right). Localization of HeV 
F was analyzed with anti-F 5G7 antibodies, and PIV5 F analysed with mAb F1a 
(green) (A). Images were taken with a Nikon 1A confocal microscope. Images are 
representative. Scale bars represent 10 µm. (B). Z-stack images from (A) were 
collected in 0.3 µm sections, and images corresponding to top, bottom and middle 
slices are shown. Images are representative of two independent experiments 








Figure 3.3. Expression and stability of PIV5 F WT and LIZ are comparable. 
A. A pulse-chase experiment was carried out 18 h after cells were transfected with 
2.5 µg of indicated DNA for Vero cells in six-well plates. Following a 30-minute S35 
metabolic radiolabel, samples were chased for indicated times. (B). Quantitation 
of PIV5 F and LIZ expression shown in (A). Expression levels of total F protein 
(F0+F1) were determined by band densitometry normalized to WT levels. The 








Figure 3.4. Surface and total expression of PIV5 F protein.  
(A) Surface (left) and total (right) expression levels of PIV5 F WT versus PIV5 F 
LIZ. (B) Quantitation of expression levels (left) and percentage cleavage (right) of 
surface and total PIV5 F protein. The averages represent three independent 
experiments, each carried out in duplicate. The LIZ mutant was compared to WT 






Figure 3.5. Flow cytometry to quantify expression of prefusion PIV5 F only 
present at the surface of cells.  
Flow cytometry was performed on Vero cells transfected with WT or LIZ PIV5 F. 
The averages represent three independent experiments, each carried out in 
duplicate. The LIZ mutant was compared to WT using Student’s t-test. *, P<0.05; 








Figure 3.6. Mutations to the L/I zipper of PIV5 reduce F-mediated fusion 
activity.  
(Left). Syncytia assay. BHK cells plated in six-well plates were transfected with 
2.5 µg of total DNA with the PIV5 HN attachment protein alone, PIV5 WT F and 
HN or PIV5 LIZ F and HN. Syncytia formation was analyzed 24 h post-transfection. 
Images were taken with a Nikon TS100 microscope. White arrows indicate 
syncytia. Images are representative of two independent experiments, each carried 
out in triplicate. (Right). Luciferase reporter gene assay to quantify F fusogenic 
activity. Vero cells in 24-well plates were transfected with 1.0 µg total DNA with a 
T7 promoter plasmid and PIV5 F WT+HN or pIV5 F LIZ+HN. The following day, 
Vero cells were overlaid with BSR cells and incubated for 3 h to allow for luciferase 
production. Luciferase activity was measured using a luciferase assay system. The 
average represents three independent experiments, each performed in duplicate. 





Figure 3.7. Thermal triggering assay to observe PIV5 F WT and LIZ 
prefusion thermostability.  
Cells expressing surface PIV5 F or WT were exposed to 4, 37, 55, 60 or 65 °C for 
15 min. Cells were immediately placed on ice for 15 min and prepared for flow 
cytometry using PIV5 mAb F1a. The average represents two independent 
experiments, each performed in triplicate. The LIZ mutant was compared to WT 







Chapter 4 : ROLES OF HUMAN METAPNEUMOVIRUS MATRIX 
PROTEIN BEYOND ASSEMBLY 
This work was performed in collaboration with Dr. David Stein and Dr. Hong 
Moulton (Oregon State University), who we consulted with for the design of PPMO. 
Drs Stein and Moulton also synthesized the arginine-rich peptide conjugated to the 
PPMO used in figure 4.5 – 4.9. In addition, Dr. Gaya Amarasinghe (Washington 
University in St. Louis) produced the IP/MS data shown in Table 1, and Dr. Cheng-
Yu Wu (University of Kentucky) performed all qRT PCR experiments (Figure 4.8), 
as well as immunofluorescence in Figure 4.9 A and C. 
Introduction 
Human metapneumovirus (HMPV) is an enveloped virus that was 
reclassified in 2016 from the Paramyxovirdae family into the Pneumoviridae family 
[156]. It was discovered in 2001, although it is known to have been in circulation 
for several decades before its isolation—at least since 1958 [157]. Most people 
contract HMPV by the age of five, and reinfections are common throughout life 
[157, 158]. Clinically, HMPV manifests as flu-like symptoms in patients; however, 
for preterm infants, immunocompromised individuals and the elderly, HMPV inflicts 
more severe symptoms including asthma exacerbation, bronchiolitis and 
pneumonia, putting this category of patients at higher risk of mortality [157, 
159-162]. For HMPV, there is currently no available FDA-approved
therapeutic or vaccine, and much of its treatment involves supportive therapy
[163]. It is therefore important to elucidate novel and effective therapeutic targets
by understanding the molecular basis of HMPV infection.
The pneumovirus family contains two important human pathogens: HMPV 
and respiratory syncytial virus (RSV) [156]. The closely related viruses are highly 
heterogeneous in shape and size, with some particles bearing filamentous or 
asymmetric morphology, and others being spherical [157, 164-166]. HMPV viral 
particles feature host-derived membranes that are studded with multiple copies of 
the following surface glycoproteins: the attachment protein (G), which although is 
68 
necessary for attachment and entry for the closely related Paramyxoviridae, is 
dispensable in pneumoviral infection [57, 167]; the fusion protein (F), which 
undergoes large scale conformational changes to merge the viral and target 
membrane [168, 169]; and the small hydrophobic protein (SH), which is a proposed 
viroporin [169]. 
Upon entry and release of the HMPV viral genome into the host cell, 
discrete cytosolic pockets termed inclusion bodies (IBs) are formed [120]. HMPV 
IBs are membrane-less structures, and by analogy to similar viruses are thought 
to be formed through liquid-liquid phase separation (LLPS) [77, 80, 170, 171]. IBs 
are commonly formed among NNS RNA viruses and in most cases function as 
primary sites of efficient viral replication and transcription [76, 77, 120, 172-178]. 
Within IBs, there is a viral RNA-dependent RNA polymerase complex, which 
consists of the large protein (L) and the polymerase cofactor, phosphoprotein (P). 
The polymerase complex uses viral genomic (v)RNA encapsidated nucleoprotein 
(N) as a template for replication and transcription. The matrix 2-1 (M2-1) protein
can also be associated with the polymerase and facilitates processivity, allowing
for efficient transcription and translation in the IBs [179, 180].
Pneumo- and paramyxovirus vRNA is encapsidated by the nucleoprotein 
(N) and flanked by a leader (le) sequence at the 3’ end, and a trailer (tr) region at
the 5’ end, with both le and tr being variable in length [32, 181]. In addition,
individual genes are flanked by shorter (10-13 nt long) gene start (gs) and gene
end (ge) sequences. For transcription to occur, the viral polymerase first
associates with the le promoter sequence and scans the vRNA template for the
first gs sequence. At the gs, the polymerase initiates transcription, with the gs
playing a role in directing the capping of the RNA transcript. Transcription
continues until the polymerase encounters the ge, where it creates a poly(A) tail
and releases the nascent viral mRNA. The polymerase subsequently moves on to
the next ge signal and transcribes each gene independently through this
mechanism [32, 181-183]. The mRNA products are thought to be trafficked out of




same encapsidated vRNA that is carried by the virus into cells is used to generate 
antisense genome RNA (+RNA), which is further used to generate nascent copies 
of vRNA. In this case, the polymerase interacts with the vRNA le region to start 
antigenome synthesis but ignores ge and gs signals to create a full antisense RNA, 
that in turn serves as a template for more vRNA production [32, 120, 182]. A recent 
report from our group showed that HMPV transcription and replication rates are 
increased between 6 hours post infection (h.p.i.) to 12 h.p.i. In fact, HMPV IBs 
coalesce in an actin-dependent manner during infection to boost the efficiency of 
replication and transcription [120].  
 Although the presence of the N and P proteins are the basic requirements 
for pneumovirus IB formation [174, 185],  the matrix (M) proteins of RSV and the 
paramyxovirus NiV have been documented to be associated with inclusions [76, 
95, 108]. NiV M was shown to colocalize with inclusion body species that are 
present at the plasma membrane later in infection [76], corroborating a 
longstanding observation that NNS RNA virus M proteins serve as adaptors 
between viral ribonucleoproteins (RNP)s and the plasma membrane [44, 166, 186, 
187]. Indeed, for many non-segmented negative sense (NNS) RNA viruses, the 
matrix protein is thought to be a master regulator of viral infection. Viral matrix 
proteins are typically peripheral membrane proteins and for Newcastle disease 
virus (NDV), HMPV, RSV, and Ebola virus (EBOV), interact with the plasma 
membrane through electrostatic interactions: positively charged surfaces on the 
matrix proteins associate with the negatively charged inner leaflet of the plasma 
membrane [83, 188-190]. Underneath the plasma membrane, like I-BAR domain-
containing proteins [191], M proteins polymerize to form a grid-like array and 
induce membrane curvature and allow for budding of nascent viral particles [44, 
83, 186, 187, 189, 190, 192]. For some viruses such as EBOV, VP40 alone can 
form authentic virus-like particles [190]. In addition to RNPs, M is known to 
associate with the cytoplasmic tails of surface glycoproteins, thus M is not only 
important for budding but also for assembly of viral particles, particularly at late 
stages during infection [44, 108, 193].  
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Despite M having been well-established as a key player in late-stage 
infection, some of the function of M has proven to be enigmatic. Recent studies 
have shown that M may play roles in early infection: several NNS RNA matrix 
proteins traffic to the nucleus in early infection although NNS RNA viruses are 
mostly known to only involve cytosolic steps in their life cycle [95, 194-196]. Upon 
trafficking to the nucleus shortly after being synthesized, NiV M is ubiquitinated. 
This ubiquitination is not only important for nuclear exit, but also allows the matrix 
protein to associate with the plasma membrane upon nuclear export and facilitates 
its performance in assembly and budding [161]. Another unexpected feature of a 
pneumovirus matrix protein, HMPV M [83], is that to date, it is the only NNS RNA 
viral matrix protein that was co-crystalized with calcium. Although calcium is a 
potent signaling modulator [197], it is unclear what roles calcium binding confer to 
HMPV M.  
In this study, we show that HMPV M is trafficked to the nucleus, and the 
timing of nuclear transit coincides with the previously examined height of HMPV 
replication and transcription [120]. Though extensive work has elucidated the 
mechanisms of nuclear entry and exit for some NNSV M proteins [194, 198, 199], 
there is a gap in our knowledge on the purpose of nuclear transit for the majority 
of these cases. Thus, our studies sought to bridge the gap by knocking down the 
matrix protein early in infection to address effects on early infection. We utilized 
antisense phosphorodiamidate Morpholino oligomers to selectively knock down 
HMPV M during infection to dissect the role of M during the course of infection. 
Preliminary data show that HMPV M is critical for establishing viral replication and 
transcription. Additionally, we address the role of calcium binding in HMPV M by 
examining expression and conformation of HMPV M with mutations in the calcium-
coordinating residues. We find that in addition to the previously published role of 
calcium in thermostability of the protein [83], calcium is important in proper folding 
of the matrix protein. 
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Results 
HMPV M travels in and out of the nucleus during the course of infection. 
The bulk of the NNS RNA viral life cycle occurs within the cytosol. Outside 
of the Bornaviridae family, Mononegavirales do not require nuclear events for 
transcription, replication, and assembly. One of the key modulators of infection is 
the matrix protein, which interacts with viral and cellular proteins to play essential 
roles in late infection to assemble and bud virions from the host cell. Interestingly, 
several matrix proteins of NNS RNA viruses have been shown to associate with 
the nucleus and with nuclear factors [95, 194, 195, 198]. Table 4.1 shows an 
interactome generated from immunoprecipitation (IP) of HMPV M from transfected 
cells, followed mass spectrometry (MS) of host-associated proteins. Along with 
HMPV M transfection, cells were treated with polyinosinic:polycytidylic acid, poly 
(I:C), a synthetic double stranded RNA that potently mimics viral infection and 
induces Toll-like receptor 3 (TLR 3), MDA5, and RIG-I response [200, 201]. Among 
the list of interacting proteins with HMPV M is the GTP binding nucleoprotein Ran, 
a nuclear import factor [202] (Table 4.1). This IP/MS data supports an interaction 
of HMPV M with some nuclear factors, potentially consistent with HMPV M traverse 
to the nucleus. To follow up on the possibility of M being trafficked into the nucleus, 
we infected cells with wild type (WT) HMPV, at a multiplicity of infection (MOI) of 
4, and fixed cells at indicated times for immunofluorescence (IF) analysis. Our data 
show that by 6 hours, there is evidence of matrix protein synthesis in punctate 
structures within the cell. By 10 hours post infection (h.p.i.), M is primarily present 
in the nucleus (Figure 4.1). As infection progresses from 12 h.p.i. through 30 h.p.i., 
the presence of M in infected cells shifts to favor a cytosolic distribution, with most 
of M associated in filamentous structures as infection progresses past 18 hours 
(Figure 4.1 D – F; I – L). 
HMPV M moderately affects minigenome replication 
Some NNS RNA virus matrix proteins are documented to affect viral 
replication and transcription. For example, in a minigenome assay, both EBOV 
matrix proteins (VP24 and VP40) were discovered to inhibit viral replication [109]. 
Previous work has shown that the highest rates of HMPV replication occur 
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between 6 – 12 h.p.i. [120], consistent with the hypothesis that nuclear localization 
of M may prevent replication inhibition, and in line with the timing of nuclear 
accumulation of M shown in Figure 4.1. From these observations, we hypothesized 
that HMPV M has a negative effect on viral replication and transcription, and is 
therefore sequestered away from the cytosol into the nucleus to allow viral 
replication to efficiently occur. To test this hypothesis, we employed a minigenome 
luciferase reporter gene system, kindly provided by Dr. Rachel Fearns, Boston 
University. BSR cells were transfected with the components required for efficient 
viral replication (HMPV N, P, L, and M2-1) in addition to a reporter gene plasmid 
containing a luciferase reporter cassette. We assessed the efficiency of reporter 
gene translation as a readout for the efficiency of viral transcription and replication 
in the context of increasing amounts of M. Our data show that at adding M to the 
reporter gene assay moderately affects reporter gene activity. It is noteworthy that 
upon addition of 2.0 µg of HMPV M to the minigenome system, we notice an 
inconsistency in the general trend of decreased minigenome activity in response 
to increasing amounts of M. It is possible that this data point is an experimental 
outlier. Further experimental repititions are necessary to determine if the change 
at this concentration of M is significant (Figure 4.2).  
Given the moderate effect of M on the minigenome system, we were 
interested in examining the role of M the context of infection. To examine the 
hypothesis that HMPV M has effects on replication and transcription during the 
course of infection, we designed antisense peptide-linked phosphorodiamidate 
Morpholino oligomers (PPMOs) to knock down HMPV M protein levels (Figure 4.3 
A). PMOs are nucleoside analogs that sterically inhibit protein synthesis [203]. 
Linking an arginine-rich sequence to the 5’ end of the PMO sequence allows for 
non-toxic, efficient delivery across cellular membranes [121]. PPMOs can be 
engineered to target the 5’untranslated region (UTR) and AUG start codon, thereby 
preventing the assembly of the small and large ribosomal subunits [123, 203] 
(Figure 4.3 C and D). Recently, PPMOs have shown to be potent, easy-to-use 
inhibitors of specific viral protein translation during infection [122, 170, 204].  
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To design a PPMO to specifically target HMPV M, we examined the 5’UTR 
of 44 disparate strains of HMPV (Figure 4.3; appendix i). We designed an 
antisense PPMO based on the conserved 13 nucleotide sequence of the 5’UTR 
combined with the first 12 nucleotides of the matrix protein nucleotide sequence, 
using CAN97-83 as our reference sequence, since it is the strain used in this study. 
This yielded a 25 nucleotide-long antisense PPMO for HMPV M knockdown. 
PPMO are incredibly specific, requiring only a five nucleotide mispairs for ablation 
of function [123, 205]. Our analysis shows that compared with 5’UTR regions of 
other viral proteins, there is not enough sequence identity for M PPMOs to have 
off-target effects (Figure 4.4) In addition to the M-specific PPMO, we designed a 
negative control scrambled PPMO, which is a nonsense PPMO with no known 
cellular or viral target. 
PPMO cell toxicity and knockdown of M 
To address the role of M early in infection, we initially examined the effect 
of the PPMO on cell viability with different concentrations of PPMO, up to ten times 
the required amount for inhibition, in 2-fold serial dilutions. Our results demonstrate 
that even at the highest amounts, there is no significant effect of the PPMO on cell 
viability (Figure 4.5). We next tested the efficiency of the PPMO to knockdown 
HMPV M during infection with a recombinant GFP-expressing (rg) HMPV. We 
found that without treatment, by 24 h.p.i, M had increased by approximately 5-fold 
compared to samples taken from our 6 h.p.i time point. However, when PPMO 
were added at 0 h.p.i, expression between 6 h.p.i and 24 h.p.i was maintained at 
similar levels, indicating that the PPMO was able to prevent significant translation 
of HMPV M (Figure 4.6 A and C). 
We also addressed the effect of the M-specific PPMO on another viral 
protein, F. We found that surprisingly, despite lack of significant sequence 
similarity with the PPMO target, F synthesis was also dramatically reduced (Figure 
4.6 B and D). These data suggest that knocking down M potentially affected the 
transcription of other viral proteins. 
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PPMO reduce rgHMPV titer, but not rgPIV5 or rgRSV 
Based on our surprising result with HMPV F, we were interested in whether 
the PPMO potentially affected the establishment of infection in cells. We infected 
cells with rgHMPV at an MOI of 4, and then treated cells at 0, 4, and 6 h.p.i., with 
either the scrambled PPMO or the M-specific PPMO. At 24 h.p.i., we fixed and 
visualized cells, and also performed flow cytometry to quantify the number of cells 
that expressed GFP as a readout of the number of infected cells. Our results show 
that after addition of the M-PPMO at the indicated times post infection with analysis 
at 24 h.p.i., the number of infected cells is reduced, suggesting that M plays roles 
during early infection (Figure 4.7 A and D). Additionally, we wanted to address 
whether the effect the PPMO was specific to HMPV, so we performed the same 
analysis on two related viruses: RSV and the paramyxovirus, PIV5. There was no 
significant effect of the HMPV M-targeting PPMO on the number of infected cells 
present when in the case of either rgPIV5 or rgRSV, suggesting that M PPMO were 
specific to reducing HMPV infection (Figure 4.7 B, C, E, F).  
PPMO knockdown of M shows a dramatic reduction of viral genomic and 
mRNA but shows no effect on cellular mRNA  
Having established that the number of cells infected is reduced specifically 
for HMPV following PPMO treatment, we analyzed the effect of the PPMO on viral 
mRNA, and compared it to cellular mRNA following infection. Cells infected with 
HMPV at a MOI of 4 were treated with the scramble or M-specific PPMO at 0 h.p.i. 
At indicated times post infection, M-PPMO-treated and control cells were 
harvested, with RNA extracted for quantitative real time polymerase chain reaction 
(qRT-PCR) analysis. Our data show that for all time points, M-PPMO treatment 
resulted in a dramatic decrease for all viral mRNA (Figure 4.8 A-C). At 6 and 8 
h.p.i., specifically, the decrease in viral mRNA occurred according to the gene
order: PPMO treatment rendered N most affected, followed by P, M, F, M2-1, M2-
2, SH, and G, with L being the least affected in the above order. As infection
progressed, we observed by 12 h.p.i. that PPMO treated infected cells only
produced approximately 10% of all viral mRNA, except for L which produced
almost 50% viral mRNA compared to the control sample.
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Notably, the longer infection progressed, the more dramatic the effect of M 
knockdown had on the efficiency of viral mRNA production. By 24 h.p.i., there was 
at least a 94% decrease in mRNA production per gene, contrasted with the 6-hour 
time point, where we observed up to a 75% decrease in mRNA production. Unlike 
with viral mRNA, host mRNA remained unchanged throughout the time course 
infection, indicating a specificity of the M PPMO knock-down in targeting viral 
mRNA production. Additionally, as a representative of viral genomic (v)RNA, we 
similarly tested the expression of P vRNA in response to PPMO during infection. 
Our results show that vRNA production was ablated in response to PPMO 
treatment (Figure 4.8 D), whereas the control cells continued to produce vRNA 
during infection as previously reported [120]. Taken together, these data suggest 
that the presence of M during infection has a significant impact on establishment 
of infection by positively affecting viral transcription and replication. 
PPMO knockdown of M results in changes of inclusion localization during 
infection 
IBs are sites of efficient viral replication and transcription. For HMPV, they 
coalesce in an actin-dependent manner during infection, a process which is 
postulated to increase viral genomic and mRNA production [120]. Moreover, 
several NNS RNA viral M proteins are known to interact with viral RNPs, priming 
them for assembly at the plasma membrane [44, 186]. Since our current data 
suggest that HMPV M informs early infection events, we sought to understand 
whether M affects replication and transcription by influencing inclusion body 
morphology and localization. To address this, we performed IF combined with 
fluorescence in situ hybridization (FISH), using probes specifically designed to 
detect the vRNA species in cells during a time course infection as previously 
designed [120]. Using two physiologically relevant cell types; human 
adenocarcinoma alveolar basal epithelial cells, A549 [206], and non-tumorigenic 
human bronchial epithelial cells BEAS-2B [207], we addressed the formation of 
inclusion bodies with and without M PPMO treatment (Figure 4.9). We observed 
that during time course of infection, as previously reported [120], HMPV IBs 
coalesce over time, forming larger perinuclear inclusions. By 18 h.p.i. in BEAS-2B 
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cells, the N protein, which is a critical component of viral ribonucleoproteins, forms 
filamentous structures (Figure 4.9 B), consistent with previous reports showing that 
M and N associate at the plasma membrane within cell-associate branched 
filaments and within budding filamentous viral particles [208, 209]. We also 
observed that by 24 h.p.i., N and vRNA were present in intercellular extensions, 
corroborating a previously observed result [208]. Conversely, for our time course 
data on M-PPMO treated cells, we were unable to identify N or vRNA in 
filamentous structures in both cell types. Moreover, IBs and vRNA appeared to be 
confined to the perinuclear region even at later time points (18 and 24 h.p.i.), 
suggesting a deficiency in trafficking to the plasma membrane. Together, these 
data indicate that HMPV M is an important mediator in trafficking vRNA to the 
plasma membrane. It still remains unclear whether blockade of vRNA movement 
to the plasma membrane as a result of M knockdown is linked to the reduction in 
transcription and replication, as reduced levels of other viral proteins could also 
influence vRNA trafficking.  
Mutations to the calcium binding site of HMPV M effect protein 
conformation 
Our studies of the matrix protein sought to understand how its unique 
features such as nuclear sojourn and calcium binding potentially effect HMPV 
infection. To this end, we also investigated the effect of mutating calcium 
coordinating residues. Leyrat et al. previously published a high-resolution crystal 
structure of HMPV M, which to date is the first NNS RNA matrix protein to have 
been co-crystalized with calcium. They identified residues E24, D26, L28, and 
K101 as directly forming a pentavalent interaction to secure calcium binding within 
the N-terminal region of each HMPV M monomer [83]. To examine the potential 
role of calcium binding for HMPV M, we made individual alanine substitutions to 
each calcium coordinating residue listed above, including E103, an adjacent 
residue to the calcium binding site. In addition, we created a quadruple mutant 
which featured all four calcium binding proteins mutated to alanine (Figure 4.10 A). 
 Our initial interest with these mutants was to investigate whether removal 
of calcium-coordinating residues potentially affected the localization of the matrix 
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protein when transfected into cells. Our results show that mutagenesis of the 
calcium binding site does not result in abberant localization; WT M and mutants 
were similarly distributed throughout the cell (Figure  4.10 B). To quantify the 
expression of mutants relative to WT, we expressed plasmids containing WT M or 
each mutant listed in Figure 4.11 A in A549 cells, and performed Western blotting. 
Our results support our initial finding with IF that all the mutants are detectable, 
and none of the mutations in residues that are involved in the direct interaction with 
calcium significantly change expression profiles (Figure 4.11).  
Using a thermal shift assay, Leyrat et al. demonstrated that removal of 
calcium resulted in a 25ºC shift in melting temperature, showing that the binding of 
calcium to HMPV M increases thermostability and potentially contributes to its 
structural rigidity [83]. We were interested in testing whether this calcium binding 
also affected the conformation of the matrix protein when expressed in a cellular 
environment. To address this question, we performed radioimmunoprecipitation 
studies on WT M along with its mutants using a polyclonal avian metapneumovirus 
C matrix antibody that cross-reacts with HMPV M.  This polyclonal antibody works 
well for Western blotting, which requires antibody interactions with a denatured 
protein, supporting the idea that this polyclonal antibody can recognize sequence-
specific epitopes. We contrasted this with radioimmunoprecipitation studies 
performed with the conformation specific anti-HMPV M monoclonal antibody JOJ, 
which is conformational specific, as shown by its lack of reaction in Western 
blotting applications. Our data show that mutants of E24A, D26A, L28A, K101A, 
and the 4A mutant, M no longer binds the conformational antibody, but maintain 
binding to the sequence-specific antibody (Figure 4.12). Interestingly, we noted 
that the L28A and 4A mutants produced higher molecular weight M species (Figure 
4. 12), suggesting that L28 potentially plays a role in regulating M oligomerization. 
Additionally, the mutant E103A, which is proximal to the calcium binding site  but 
not directly involved in calcium binding also was able to bind the sequence-specific 
antibody, providing evidence that the calcium coordinating residues in particular 






 Traditionally, our understanding of NNS RNA matrix proteins have centered 
on their roles in the assembly, budding, and egress of viral particles—much of 
which occurs at during late stages of infection [44, 186]. NNS RNA viral M proteins 
are known to form a highly ordered layer underneath the plasma membrane, 
inducing membrane curvature and facilitating the budding of new viral particles [83, 
191, 192]. However, more recent reports document characteristics of M that 
suggest roles in addition to its mediation of late-stage infection. For example, 
henipavirus matrix proteins are imported into the nucleus and then exported before 
they arrive at the plasma membrane for assembly. For HeV M, the positive charge 
at position 258 is critical for nuclear transit, and specifically, the K258 residue must 
be ubiquitinated before the protein can exit the nucleus and associate with 
membrane structures [96, 194].  Both of the HeV M mutations that prevented either 
nuclear entry or nuclear exit also failed to associate with the plasma membrane 
and prevented virus budding and egress [96]. Although the lack of cytosolic 
distribution of nuclear-accumulated M provides a straightforward explanation for 
the lack of membrane association, it is less clear why mutations that prevented the 
import of M into the nucleus also result in a similar deficiency in assembly, since 
M was readily available in the cytosol. The authors speculate that in addition to 
monoubiquitination, M must form important associations within the nucleus that 
enable subsequent membrane association to occur [96]. 
 As previous studies show that several NNS RNA viral matrix traffic to the 
nucleus, and our IP/MS data suggested that HMPV M associates with Ran, a 
nuclear GTP factor, we probed whether HMPV M also demonstrated nuclear entry 
during infection. Our results show that between 6 and 12 h.p.i., HMPV M is mainly 
localized within the nucleus, and by 18 - 24  h.p.i., becomes associated in 
filamentous structures consistent intercellular extensions and budding filamentous 
virions [208]. Previous studies of HMPV, HeV, and NiV show that when transfected 
alone, HMPV and henipavirus M do not demonstrate the same degree of steady-
state nuclear retention that we observed for infection  [96, 210, 211], indicating that 
infectious conditions promote nuclear accumulation, especially early in infection. 
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Interestingly, we note that the nuclear entry of the HMPV matrix protein coincides 
with the timing of exponential HMPV replication and transcription that was 
previously reported [120]. Our minireplicon system showed that the presence of M 
had a moderate yet significant inhibitory effect on HMPV minigenome replication 
and transcription, and thus led us to hypothesize that one consequence of HMPV 
M sequesteration in the nucleus is to curtail inhibition of efficient replication and 
transcription of the viral genome. An extension of this hypothesis is that the timely 
export of M would then inhibit viral replication and transcription, to favor assembly 
at the plasma membrane. 
Infection with recombinant Sendai virus (SeV) recombinant NiV, 
recombinant measles virus (MeV), and recombinant RSV, all lacking M, or SeV 
infection with siRNA knockdown targeted against M show severe deficits in 
assembly and budding, but no significant effects in replication and transcription in 
cases where they were assessed [212-216]. Interestingly, when mutants were 
created to block NiV M from exiting the nucleus, NiV M was also found to be 
present in perinuclear IBs. The presence of NiV M presumably occurred before 
nuclear import, and inclusion bodies formed in this manner were hypothesized to 
be aggresomes [217]. Moreover, RSV lacking M results in N retention in IBs, and 
prevention of viral filament maturation [216]. Although the effects of M during early 
infection of the paramyxovirus SeV suggest that M does not affect replication and 
transcription during infection [214], studies on RSV show changes to IBs in the 
absence of M [216] and direct quantitation of viral genome and mRNA in response 
to M depletion had not yet been investigated in pneumoviruses until this study. Our 
knockdown of M resulted in considerable decreases in viral transcription and 
replication. We found that along with M knockdown was an accumulation of N-
containing inclusion bodies at the perinuclear region, similar to results obtained for 
RSV [216].  
Based on the interaction of M with RNPs previously discussed, it was not 
surprising that knocking down M would reduce the placement of N and IBs at sites 
closer to the plasma membrane; however, our unexpected observation of a large 
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decrease in efficiency of viral replication and transcription after M knockdown 
suggests a potential link between inclusion body dynamics mediated by M and the 
efficiency of vRNA and viral mRNA production. Previously, our group has shown 
that IBs interact with actin during infection to coalesce and boost replication and 
transcription [120]. During infection, M localizes within branched filamentous 
structures, which are also populated with actin. Actin remodels cells for efficient 
viral transmission [208]. It is possible that HMPV M makes contact with both actin 
and vRNP during infection to mediate trafficking of vRNPs to the plasma 
membrane for assembly. In terms of how this potentially contributes to the 
efficiency of viral replication, the trafficking of vRNPs away from their sites of 
synthesis may prevent overaccumulation of vRNPs. Indeed, recent data has 
shown that NiV IBs can act as aggresome-like compartments [217]. If this also 
occurs for HMPV inclusions in the context of overaccumulation of viral proteins, 
lack of trafficking of N and vRNA from IBs could inflict deleterious effects on proper 
IB replication and transcription function. 
We cannot rule out that HMPV M contributes to the regulation of replication 
and transcription while it is within the nucleus. HeV M, NiV M, NDV M, SeV M, MeV 
M, canine distemper virus (CDV) M, influenza A, and influenza B (IAV and IBV) 
polymerase proteins have been shown to interact with acidic leucine-rich nuclear 
phosphoprotein 32 family member B (ANP32B). [210, 218-221]. ANP32B is critical 
for host range determination of IAV and IBV [218, 220]. Interestingly, its interaction 
with henipavirus M drives an increase in steady-state nuclear accumulation of 
ANP32B. It has been proposed that henipaviral M associations with ANP32B may 
help with nucleocytoplasmic shuttling or with inhibiting host responses to favor viral 
infection [210]. Moreover, recently, ANP32B was found to regulate immune 
responses in mice [222]. Although not found to directly interact with bovine RSV 
M, ANP32B can indirectly interact with proteins through CRM1, an adaptor protein 
for CD48 mRNA transport, further implicating M in associations with immune 
response modulators  [221, 223]. The CRM1 protein has been identified to mediate 
nuclear shuttling of RSV M [199]. With HMPV M being closely related to RSV M, it 
is possible that CRM1-mediated interactions with either CRM1/CD48 mRNA 
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and/or ANP32B and potential downstream effectors occur during infection. Follow-
up studies with IP/MS of nuclear-isolated M, in addition with chromatin 
immunoprecipitations (ChIP), would be helpful in identifying unique nuclear 
interactors and would enhance our understanding of the roles of HMPV M. In 
addition, with M postulated to interact with cytoplasmic tails of surface 
glycoproteins [44, 186], although our data show that the fusion protein is 
decreased in response to M knockdown, further investigation into the proportion of 
surface-exposed M and F would contribute to our understanding of HMPV M in 
viral assembly.  
Our data also show that although mutations to the calcium binding region of 
HMPV M do not affect cytosolic localization, there is a difference in folding (Figure 
4.11), although it is not known whether this difference in folding is specific to the 
calcium binding portion of the protein only, or whether it affects the ultrastructure 
of the protein, as the recognition site for the antibody is currently unknown. Follow 
up studies involving crystallization of the mutants are necessary to validate lack of 
calcium interaction, as well as changes in conformation. These results build on the 
previous finding that HMPV calcium binding increases thermostability [83], 
suggesting that the conformational changes contribute to the decrease in 
thermostability as a result of a lack of calcium binding.  
HMPV M makes contacts with the membrane using its concave surface and 
the calcium binding pocket sits at the convex surface [83]. Although I hypothesize 
that conformational changes conferred by calcium binding likely most affect the 
concave surface, given its proximity to the calcium binding site, it would be 
important to examine whether calcium binding affects membrane association by 
transmitting additional conformational changes either throughout the protein or 
facilitates changes in interactions with currently unidentified membrane proteins 
and/or lipids.  Moreover, the residues in HMPV M which potentially engage in 
contact with actin and/or vRNP association for assembly occur are currently 
unknown. In addition, there is a gap in our knowledge of whether HMPV M, like 
EBOV VP40, binds RNA directly [224]. It may be that the because the calcium 
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binding site, a cationic site, facing away from the membrane towards the cytosol, 
would mediate interactions with negatively charged molecules such as RNA. 
Finally, the role of calcium binding in maintaining the structural integrity of nascent 
virions is worth investigating. 
Taken together, our data supports a model where while in the cytosol, HMPV 
M associates with actin to recruit vRNPs from IBs to the membrane, and 
recruitment of vRNPs to the membrane plays a role in maintaining the homeostasis 
required for efficient vRNA and viral mRNA production. This effect of maintaining 
inclusion body homeostasis is particularly pronounced during mid-to-late stages of 
infection, when IBs coalesce in an actin-dependent manner, and reach maximal 
transcription and replication activities. This potentially works synergistically with 
nuclear HMPV M, which could interact with (a) nuclear factor(s) to mediate cellular 
responses that are otherwise detrimental for viral infection. In addition, calcium 
binding of HMPV M facilitates necessary conformation of M to mediate its multitude 
of functions.   
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sp|P23396|RS3_HUMAN RPS3 40S ribosomal protein S3 17.1 
sp|P42704|LPPRC_HUMAN LRPPRC 
Leucine-rich PPR motif-containing 
protein, mitochondrial 5.2 
sp|P62070|RRAS2_HUMAN RRAS2 Ras-related protein R-Ras2 4.7 
sp|O95831|AIFM1_HUMAN AIFM1 
Apoptosis-inducing factor 1, 
mitochondrial 4.5 
sp|P07437|TBB5_HUMAN TUBB Tubulin beta chain 4.2 
sp|P68366|TBA4A_HUMAN TUBA4A Tubulin alpha-4A chain 4.1 
sp|P10301|RRAS_HUMAN RRAS Ras-related protein R-Ras 3.3 
sp|Q8NHP6|MSPD2_HUMAN MOSPD2 
Motile sperm domain-containing 
protein 2 2.9 
sp|P62269|RS18_HUMAN RPS18 40S ribosomal protein S18 2.8 
sp|P62829|RL23_HUMAN RPL23 60S ribosomal protein L23 1.8 
sp|P62263|RS14_HUMAN RPS14 40S ribosomal protein S14 1.7 
sp|P35244|RFA3_HUMAN RPA3 Replication protein A 14 kDa subunit 1.6 
sp|P23284|PPIB_HUMAN PPIB Peptidyl-prolyl cis-trans isomerase B 1.3 
sp|P42677|RS27_HUMAN RPS27 40S ribosomal protein S27 1.1 
sp|Q96CJ1|EAF2_HUMAN EAF2 ELL-associated factor 2 1 
sp|P12236|ADT3_HUMAN SLC25A6 ADP/ATP translocase 3 1 
sp|P78347|GTF2I_HUMAN GTF2I General transcription factor II-I 1 
sp|Q13509|TBB3_HUMAN TUBB3 Tubulin beta-3 chain 1 
sp|Q15165|PON2_HUMAN PON2 Serum paraoxonase/arylesterase 2 1 
sp|P62826|RAN_HUMAN RAN GTP-binding nuclear protein Ran 1 
sp|Q00325|MPCP_HUMAN SLC25A3 




reticulum calcium ATPase 1 1 
sp|P07900|HS90A_HUMAN HSP90AA1 Heat shock protein HSP 90-alpha 1 
sp|P62249|RS16_HUMAN RPS16 40S ribosomal protein S16 1 
sp|P15559|NQO1_HUMAN NQO1 
NAD(P)H dehydrogenase 
[quinone]c 1 1 
sp|P51114|FXR1_HUMAN FXR1 
Fragile X mental retardation 
syndrome-related protein 1 1 
sp|P62820|RAB1A_HUMAN RAB1A Ras-related protein Rab-1A 1 
sp|P46781|RS9_HUMAN RPS9 40S ribosomal protein S9 1 
sp|Q8TF66|LRC15_HUMAN LRRC15 
Leucine-rich repeat-containing 
protein 15 1 
sp|Q58FF8|H90B2_HUMAN HSP90AB2P 
Putative heat shock protein HSP 90-
beta 2 1 
sp|P29966|MARCS_HUMAN MARCKS 
Myristoylated alanine-rich C-kinase 
substrate 1 
sp|P68363|TBA1B_HUMAN TUBA1B Tubulin alpha-1B chain 1 
sp|P62834|RAP1A_HUMAN RAP1A Ras-related protein Rap-1A 1 
Cells were transfected with HMPV M and subjected to poly(I:C) treatment to mimic 
viral infection. Interactome includes Ran, a GTP-binding nuclear protein that is 
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associated with nucleocytoplasmic transport. This data was generated by Dr. 






Figure 4.1. Localization of human metapneumovirus matrix protein (HMPV 
M) during infection.
BEAS-2B cells were infected with HMPV at multiplicity of infection (MOI) of 4. Cells 
were fixed at 6, 10, 12, 18, 24, and 30 hours post infection (h.p.i) for 
immunofluorescence with the monoclonal anti-HMPV antibody JOJ x (A-F). 
Colocalization profiles of DAPI, representing nuclei, and HMPV M (red; G-L). 
Images were taken with a Nikon A1 confocal microscope. Images are 
representative of at least 10 images taken for each condition. Scale bars represent 
10µm. 
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Figure 4.2. HMPV Matrix protein effect on minigenome activity. 
BSR cells constitutively expressing T7 polymerase were transfected with HMPV 
N, P, L, M2-1, and a luciferase-encoding minigenome. Altogether, these 
components termed here as the luciferase minigenome system. In the context of 
varying HMPV matrix (M) concentration (0.2 - 2µg), the minigenome reporter 
activity was examined. Experiment was performed in triplicate. n=1. Two-way 
ANOVA was performed to assess significance. *p<0.05, **p<0.005, ****p<0.0001 
88 
Figure 4.3. Peptide-linked phosphorodiamidate Morpholino oligomer (PPMO) 
mechanism of action. 
A. Consensus sequence generated based on cDNA of first 25 nucleotides (13
nucleotides comprising of the 5’untranslated region, and the first 12 nucleotides of
HMPV coding region) based 44 disparate HMPV strains. Accession numbers and
individual sequences included in appendix. B. Antisense PPMO generated based
on consensus sequence, with particular emphasis on HMPV M strain CAN97-83
(GenBank accession number AY297749.1). C. Simplified mechanism of viral
translation initiation by cellular ribosomal machinery in absence of PPMO. Small
ribosomal subunit containing t-RNA scans 5’ untranslated region (UTR) for start
codon. After initiation, elongation occurs, allowing for the translation of mRNA into
viral proteins. D. PPMO hybridize to 5’UTR of HMPV M, sterically blocking access
of small ribosomal subunit from the start codon. Translation is not initiated, and M




                  
 
Figure 4.4. Sequence alignments of designed PPMO on 5’untranslated 
regions of HMPV genes.  
A. Sequence alignment of scrambled (nonsense PPMO with no known cellular or 
viral targets) antisense PPMO target sequence against viral genes. B. Sequence 
alignment of antisense PPMO target (M) against 5’untranslated regions of other 
viral genes. C. Percent identity matrix of Scrambled and M-specific gene targets. 
All analyses were performed using ClustalW2  
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Figure 4.5. Cell viability after exposure to varying concentrations of the 
PPMO.  
Results of a flow cytometry experiment on A549 cells treated with indicated 
concentrations of scrambled PPMO (blue) or M-specific PPMO (red). Cell viability 
was assessed with propidium iodide. The experiment was carried out in duplicate. 
n=1.  
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Figure 4.6. Expression of HMPV viral proteins after PPMO treatment. 
A. A549 cells were treated with either 5 µM of scrambled PPMO (-PPMO), or 5 µM
of M-specific PPMO (+PPMO). PPMO were added at 0 h.p.i.
Radioimmunoprecipitation of cell lysate collected at indicated times show matrix
protein (F) expression during infection with and without M-specific PPMO
treatment. B. A549 cells treated with or without M-specific PPMO were assessed
for fusion protein (F) expression in time course. C and D, quantitation of A and B.





Figure 4.7. Effect of HMPV M-targeting PPMO on HMPV, PIV5, and RSV.  
A549 cells were infected with either rgHMPV, rgPIV5, or rgRSV at a multiplicity of 
infection (MOI) of 4. Cells were either treated with 5 µM of scrambled PPMO (-
PPMO) or 5 µM of HMPV M-targeting PPMO (+PPMO) at indicated times post 
infection. Cells were visualized at 24 hours post infection (h.p.i.) (A-C) Images 
were acquired with a Zeiss Axiovert 100 microscope. Scale bars represent 50 µm. 
Images are representative. D-F flow cytometry to quantify infection of cells in A-C. 
A-C were carried out in duplicate, n=2. Flow cytometry was performed in duplicate; 
n=1. 
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Figure 4.8. Quantitation of viral genomic (v)RNA and viral mRNA following 
M-targeting PPMO knockdown.
A-C. A549 cells were infected with WT HMPV at an MOI of 4. At 0 h.p.i, cells were
treated with either 5 µM of scrambled PPMO (-PPMO-M) or 5 µM of M-targeting
PPMO (+PPMO-M). RNA was isolated for quantitative RT PCR at indicated time
points. In addition to viral mRNA, host cellular actin and GAPDH mRNA expression
levels were also examined. D. Effect of PPMO treatment as performed in time
course for A-C was also performed using primers against vRNA. The experiment






Figure 4.9. Effect of M-targeting PPMO on inclusion body localization.  
A549 (A) and BEAS-2B cells (B) were infected with WT HMPV at an MOI of 4. At 
0 h.p.i, cells were treated with either 5 µM of scrambled PPMO (-PPMO) or 5 µM 
of M-specific PPMO (+PPMO). Cells were fixed in 4% PFA at indicated times post 
infection and visualized using a Nikon A1 confocal microscope. Scale bars 
represent 10 µm. Images are representative. C. Quantitation of distance of IBs 
from nuclei in absence or presence of M-specific PPMO of at least 10 cells per 
condition. Experiments and figure preparation of A and C were performed by 
Dr. Cheng-Yu Wu. 
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Figure 4.10. Effect of mutating calcium-coordinating residues on HMPV M 
localization.  
A. Schematic of mutations performed to the calcium binding site of HMPV M. B.
Immunofluorescence images taken with a Nikon A1 confocal microscope, showing
localization of HMPV M mutant proteins compared to wild type (WT). Scale bars






Figure 4.11. Effect of mutagenesis of calcium coordinating mutants on 
HMPV M expression. 
 A. Western blot from cell lysates of cells transfected with HMPV M. B. Quantitation 





Figure 4.12. Radioimmunoprecipitation of HMPV M following mutagenesis to 
calcium binding site with conformational and sequence-specific antibodies.  
A. Detection of immunoprecipitated WT HMPV matrix protein sequence-specific 






Chapter 5 :DISCUSSION AND FUTURE DIRECTIONS 
Overview 
 Generating effective preventative and treatment measures to battle viral 
infections requires a thorough understanding of the molecular details of viral 
infection. The work in this dissertation focuses on infectious mechanisms of non-
segmented negative sense (NNS) RNA viruses with particular emphasis on the 
factors that govern the mechanisms of viral entry facilitation. In addition, this work 
addresses an unlikely key player in early infection, and how it may function in 
eventually generating viral progeny. Previous studies on paramyxo- and 
pneumoviruses that have focused on how viral fusion (F) and attachment proteins 
(G) start infection established the foundation for the first part of this dissertation 
work. These have provided a basis for our understanding that the F protein is 
triggered in a timely manner to mediate the merger of the viral and target cell 
membranes. The factors that contribute to the metastability of the F protein before 
it is triggered include a transmembrane domain (TMD) that trimerizes with the help 
of a leucine/isoleucine (L/I) zipper. For Hendra virus (HeV), the L/I zipper is critical 
for the proper expression of HeV F in its fusogenically active form. In Chapter 3, 
we address whether this observation is relevant within the paramyovirus family by 
studying the TMD L/I zipper in the context of another paramyxovirus, parainfluenza 
virus 5 (PIV5). We establish that the TMD L/I zipper does not affect the surface or 
total expression of PIV5 F, but it is key in its functionality. This thesis also includes 
the study of a pneumovirus, human metapneumovirus (HMPV), and the early 
events after entry. In Chapter 4, the effects of the viral matrix protein, traditionally 
thought to be solely a major drive of events associated with late infection, are 
discussed in the context of establishing infection. This work has identified potential 
additional roles of the matrix protein in promoting efficient viral replication and 
transcription. This work contributes to our understanding of NNS RNA viruses but 
also highlights unanswered questions that would contribute to understanding the 




Transmembrane domain interactions facilitate functionality of 
paramyxovirus fusion proteins. 
 Enveloped viruses require carefully orchestrated events to merge their 
membranes with host cell membranes. Membrane mergers are processes that 
require repulsive “hydration forces” to be overcome in a kinetically costly process, 
as distinct membranes approach each other. Viral surface glycoproteins provide 
the basis through which membrane mergers occur between viruses and their target 
cells [225]. Paramyxoviruses and the closely related pneumoviruses typically 
engage attachment proteins for adsorption of viral particles to host cells. They also 
possess fusion proteins which undertake a major part of the membrane merging 
process by undergoing dramatic conformational changes down an energy 
gradient. Proper functionality of these surface glycoproteins serves as a critical 
jumping point of establishing viral infection [44, 134, 186].  
 Paramyo- and pneumoviral fusion proteins are classical class I fusion 
proteins: they fold into homotrimers within the endoplasmic reticulum, require a 
cleavage process to expose their fusion peptide before they become functionally 
active, and refold portions of their ectodomain into a six-helix bundle of α-helices. 
Importantly, these proteins are held in a metastable conformational state until the 
signal for triggering occurs [226]. Initial contacts during the fusion process involve 
fusion protein ectodomains, thus implicating them as important players in driving 
membrane merging [53, 143]. As such, the fusion peptides and heptad repeat 
regions have been heavily probed as therapeutic targets. The HIV drug Enfuvirtide, 
is a robust example of the outcome of such works. Enfuvirtide is an HR2-derived 
peptide that outcompetes HR2 to bind the HR1 of gp41, blocking progression of 
the fusion protein from its pre-hairpin intermediate to the six-helix bundle form 
[227]. In addition, peptides directed at the heptad repeats of henipaviruses, 
measles virus (MeV), and RSV have shown promise [228-230].  
 Given the complexity of the membrane fusion process, it is important that 
all domains of fusion proteins are well studied if effective targets are to be 
generated. While the external domains of fusion proteins have been historically 




transmembrane domains [231, 232]. Their hydrophobicity makes TMDs difficult to 
crystalize; however, development  of potent biochemical assays has allowed the 
scientific community to piece together important features of fusion protein TMDs 
that affect functionality [231]. One of the most widely studied class I fusion proteins 
is influenza HA. Reports document that replacement of the HA TMD with a 
glycosylphosphatidylinositol (GPI) anchor resulted in loss of HA functionality in 
merging membranes. Specifically, the influenza HA-GPI chimeric protein was only 
able to partially drive membrane fusion, resulting in hemifusion, a process where 
the outer and not inner membrane leaflets fuse [233, 234]. These studies 
suggested a potential role of the length of the TMD, and its spanning across both 
leaflets as important in completion of membrane fusion. Indeed, when the TMD 
was truncated, influenza HA also formed a hemifusion intermediate [235]. 
Moreover, VSV G, which is a class III fusion protein also demonstrated a length 
requirement for proper fusogenic activity—truncation mutants similarly resulted in 
hemifusion intermediates [235]. In addition to length, recent work demonstrates 
that the dissociation of the trimeric TMDs of HeV F is required to facilitate fusion. 
Introduced disulfide bonds to the N-terminus of the TMD that locked the TMD in 
trimeric state resulted in loss of fusion activity, despite some of the mutants being 
expressed at surface levels sufficient for fusion [236]. Similarly, experiments were 
carried out with PIV5 F, where the membrane proximal external region (MPER) 
was locked together using introduced disulfide bonds. The data from this work also 
shows that dissociation of trimeric interactions is important for F fluidity and 
subsequent transitions from pre-to-post-fusion conformation [237]. 
In the VSV G example listed above where truncation resulted in loss of 
functionality, a single glycine residue reintroduced to the truncation mutant 
restored 80% functionality. This example is one of the studies that showed that the 
specific amino acids present in the TMD are critical for its function [238]. The 
potential importance of individual residues in the context of viral fusion protein 
TMDs therefore spurred follow up studies from several groups that identified 
specific amino acids within individual fusion proteins as playing a role. Using 




the transmembrane domains of several class I and class II fusion proteins trimerize 
[41, 145].  The presence of an AXXG motif within the TMD of HeV F led to an 
investigation of whether this motif plays roles in trimerization and fusogenic activity 
of the full protein. This work showed that upon mutation of the AXXG glycine 
residue, G508 to alanine, leucine, or isoleucine, the surface expression and 
fusogenic activity were reduced. Interestingly, it was found that these mutations 
strengthened TMD-TMD interactions, thus pointing to a role of the G508 in 
maintaining protein expression and functionality [41]. The recent work on the 
locking of TMDs in trimers using disulfide bonds demonstrated that the mutant F 
proteins lost fusogenic activity, but where able to undergo at least initial triggering 
of conformational changes, as they lost binding to a pre-fusion specific antibody. 
[236]. Together, these studies indicate a requirement of flexibility in TMD trimeric 
interactions underline a very delicate balance in the triggering of fusion proteins.  
 The presence of a proteinaceous TMD is required for trimerization of the 
protein, with specific residues playing key roles. But what is the nature of residues 
that support the maintenance of the metastable pre-fusion structure such that it 
can still be triggered when signaled? On investigation of other potential interaction 
motifs within the TMD, a leucine/isoleucine (L/I) zipper in frame with the heptad 
repeat B L/I zipper was identified [66]. On further investigation, this L/I zipper or 
similar repeats of β-branched residues were identified in TMDs of 140 other 
paramyxo-and pneumovirus F proteins, suggesting a conserved importance 
across the viral families. Studies with HeV F identified the L/I zipper as critical in 
pre-fusion stability of the protein, as mutations to the L/I zipper resulted in 
misfolding and loss of functionality. In isolation, the TMD of HeV F was found to 
associate in trimers as determined by sedimentation equilibrium analytical 
ultracentrifugation (SE-AUC) [74].  
In chapter 3, we addressed the L/I zipper of another paramyxovirus F 
protein, parainfluenza virus 5, a paramyxovirus model system. Previously, the L/I 
zipper of HeV F was found to be important for properly maintaining prefusion 




expression of the L/I zipper mutant, suggesting a role for the L/I zipper in proper 
folding and/or trafficking the fusion protein. Our initial experiments visualized the 
placement of HeV F, and found that as suspected, the decrease in HeV F surface 
expression was because it was retained in structures close to the nucleus 
consistent with the endoplasmic reticulum (ER). ER retention reflects a defect in 
folding, which can lead to degradation in the unfolded protein response pathway 
[239], thus explaining the decrease in overall protein expression for HeV F L/I 
zipper mutants. The previous analytical ultracentrifugation data, together with the 
surface biotinylation and immunofluorescence data, show that the TMD L/I zipper 
strongly impacts trimerization of the protein as it is being synthesized, and that 
disruptions of these TMD L/I zipper interactions causes adverse effects during the 
very early stages following synthesis. In Chapter 3 our paramyxovirus model 
conversely suggests that the L/I zipper is not critical for surface expression in PIV5, 
as IF and surface biotinylation data show only a modest decrease in surface 
expression following mutations to the L/I zipper. We also used a conformation-
specific antibody to show that L/I zipper mutants were still stable in the prefusion 
form, and thermal triggering assays demonstrated a loss of prefusion conformation 
after exposure to heat, indicating that these mutants are capable of being 
triggered. 
 Despite the difference in effects of the TMD L/I zipper on surface expression 
between HeV F and PIV5 F, an interesting parallel exists for these proteins: the L/I 
zipper contributes to the functionality of the F protein. In Chapter 3, we showed 
using syncytial and reporter gene assays that, despite the presence of the mutants 
on the surface in pre-fusion form and despite the ability of these mutants to be 
triggered, TMD L/I zipper mutations rendered the protein non-functional. Our work 
corroborates a previous study that showed that one of the leucine residues present 
in the L/I zipper, L486, is an important driver of fusion. Further mutagenesis work 
in dissecting the individual roles of the other L/I residues within the zipper would 
enhance our understanding of the strength of these interactions in the context of 
functionality. It would be important to also examine PIV5 F L493, and PIV5 F L500 




a reporter gene assay. Given that our triple mutant, L486A + L493A + L500A 
readily expresses its pre-fusion form on the surface of cells, I hypothesize that with 
each of these individual mutants, there would not be severe deficits in surface 
expression and should facilitate functional studies. Within the L/I zipper, the 
position at 507 is a valine residue. Mutating this residue to alanine, leucine or 
isoleucine in the context of the wild type protein would also be important to include 
in the study of how these residues affect protein functionality. Additionally, like the 
G508 example for HeV F [41], it would be important to perform single and 
combination mutagenesis on isolated TMDs of PIV5 F for TMD-TMD oligomeric 
analyses. These studies would be helpful in investigating the mechanisms through 
which L/I zippers contribute to functionality through the lens of TMD associations.  
Although our study identified that fusion is blocked when the L/I zipper is 
mutated to alanine, we are limited in our knowledge of the stage of fusion that is 
affected.  Weakened interactions of the TMD could result in prematurely triggered 
F; however, our results in Chapter 3 that show only a modest decrease in pre-
fusion F at the surface of cells in response to L/I zipper mutations, refuting this 
idea. Moreover, Chapter 3 shows that F loses binding affinity to the pre-fusion 
conformational antibody upon triggering, suggesting that F is at least able to start 
the triggering process in absence of the L/I zipper. These observations beg the 
question of how fusion is then prevented in the TMD L/I zipper PIV5 mutants. 
Studies show that the TMD forms critical interactions with HN to secure the 
formation of the six-helix bundle. Further studies addressing whether a post-fusion 
F can be formed, whether a six-helix bundle can be formed, or alternatively 
studying the presence of pre-fusion intermediates in absence of the L/I zipper will 
assist in our understanding of the L/I zipper function.  
Therapeutic targeting of paramyxo- and pneumovirus fusion 
transmembrane domains 
 As with the Enfuvirtide example of a designed peptide inhibiting fusogenic 
activity [227], our lab group recently generated an exogenous HeV TMD-based 
peptide. The rationale behind this approach is that an exogenous TMD peptide 




premature triggering or misfolding of the full protein. When examined, co-
expression of HeV F with the HeV F TMD-targeted peptide resulted in reduction in 
F protein expression and fusogenic activity. Co-expression of peptides designed 
against PIV5 F TMD did not inhibit HMPV infection, although significantly reduced 
PIV5 F infection, suggesting sequence specificity as a factor [146]. These 
promising data suggest that in addition to ectodomains, the TMDs of viral fusion 
proteins potentially present as potent drug targets.  
 
The HMPV matrix protein in early infection 
 Once entry is successfully executed, enveloped viruses release their 
contents into host cells for propagation. As discussed in the introduction (Chapter 
1), HMPV induces formation of inclusion body structures, where the bulk of 
replication and transcription events of viral genes occur. Once genes are 
translated, the viral proteins are assembled at the plasma membrane, during what 
is termed late-stage infection for budding and egress. The matrix protein has been 
postulated for many viruses to be the main organizer of assembly, budding and 
egress [44, 193]. Although HMPV M is not involved in the ESCRT pathway, there 
is a conserved YAGL motif that facilitates higher order oligomerization necessary 
for the formation of the grid-like array underneath the plasma membrane that 
enables viral assembly and budding [211]. Like the Ebola virus (EBOV) VP40 
matrix protein, transiently expressed in 293-F cells, HMPV M has been reported to 
form virus-like particles (VLP)s [240].   
Since its discovery in 2001, there have been a limited number of studies on 
functions of the HMPV matrix protein; however, closely related viral matrix protein 
functions may shed light on some of the unknown functions of HMPV M. Despite 
low sequence similarity among Mononegavirales, there is a high degree of 
structural similarity (Chapter 1), suggesting convergent evolutionary mechanisms 
in guiding function of the protein. One of the most extensively studied 
Mononegavirales matrix proteins is EBOV VP40. EBOV VP40 consists of two 




protein, and the C-terminal domain (CTD), responsible for interactions that lead to 
and with the plasma membrane [190]. The HMPV matrix protein was also recently 
crystalized and similarly shown to have distinct CTD and NTD domains, forming 
dimers in solution; however, unlike with EBOV VP40, HMPV M has a dimerization 
interface that spans both the CTD and NTDs [83, 190]. 
Although heavily involved in the processes of assembly and budding, recent 
studies have implicated the viral matrix protein in earlier processes during 
infection. EBOV VP40 forms an octameric ring that has RNA-binding capabilities, 
and when transiently expressed in a reporter gene system, was found to have 
inhibitory effects on viral genomic and RNA synthesis [224]. In fact, several 
Mononegavirales matrix proteins have either reported associations with RNPs, or 
directly with RNA [44, 186], and in some cases inhibit viral replication and 
transcription [241-244]; a clue that the viral matrix proteins of these viruses play 
key roles at different infectious stages. In chapter 4, we found that like many other 
viral matrix proteins, HMPV M first marks its presence in the nucleus shortly after 
synthesis, before it traverses to viral filaments. As reviewed in Chapter 1, for NiV 
M, this nuclear transit is important for the membrane association and budding 
features of M [96, 194]. One important difference between EBOV VP40 and 
paramyxo- and pneumovirus matrix proteins is that VP40 contains a series of 
hydrophobic residues that deeply penetrate the plasma membrane from the 
cytosolic side [245]. The paramyxovirus Nipah virus (NiV) M provides evidence 
that at least one Mononegaviral M proteins traffics to the nucleus to gain access 
to a currently unknown factor, which may be a posttranslational modification, that 
allows for membrane association [194]. In addition, though HMPV M is known to 
interact with the viral membrane through its concave surface [83], there is currently 
no established posttranslational modification that facilitates the associations of 
HMPV M and the viral membrane contrary to what has been observed with EBOV 
VP40. Further studies into nuclear isolated M contrasted with cytosol-retained M 




Similar to EBOV VP40 and MeV M [224, 244], our data in Chapter 4 
provided evidence that in a minigenome system, HMPV M exerts inhibitory effects 
on vRNA replication and transcription. Surprisingly, in the context of a knockdown, 
there were severe deficits in the number of cells where infection had progressed 
enough for GFP expression, and with the expression of another viral protein, F. 
On further investigation, work in Chapter 4 established that HMPV M positively 
contributes to the synthesis of all viral mRNA products as well as to the efficiency 
in vRNA production, potentially leading to the observed decrease in HMPV F as a 
result of M knockdown. These studies establish a previously unidentified role in 
the process of infection of Mononegavirales: M is key in efficient transcription and 
translation of viral RNA. The use of a PPMO as a tool for knockdown is extremely 
specific [122, 204], and our analyses show no significant homology to the other 
genes to allow for cross-reaction of the PPMO with off-targets. However, out of an 
abundance of caution, we have designed a second unique PPMO to target HMPV 
M. Further studies will examine whether this second PPMO knockdown of M exerts 
the same universal effects in viral infection. In addition, extending these 
knockdown studies to RSV M would enhance our understanding of the roles 
pneumovirus matrix proteins play.  
In Chapter 4, we also showed that IB dynamics are severely affected by M 
knockdown. When M is knocked down, the movement of IBs and vRNPs towards 
the plasma membrane was thwarted. IBs and IB-like structures have long been 
studied as critical components of viral replication and transcription, and recent 
work from our lab showed that this observation is consistent with HMPV M, with 
actin driving coalescence of IBs to promote transcription and replication [120]. A 
single-particle tracking study showed that EBOV VP40 traffics along actin towards 
the plasma membrane, with plasma membrane contacts serving as an important 
modulator of assembly and budding processes [246]. Interestingly, HMPV M has 
been shown to associate in branched filaments, and these branched filaments are 
at least in part formed through remodeling of actin during infection, suggesting a 
potential link between actin and HMPV M. RSV M, Sendai virus M and Newcastle 




synthesis [247-249]. Further investigations with M and actin would be necessary 
to identify whether M acts in concert with actin to positively affect viral RNA 
production.  
IBs are membrane-less structures and on recent analysis, were shown to 
be formed through liquid-liquid phase separation (LLPS), with P as an important 
driver of droplet formation. Recent work from our lab group is the first to identify 
that HMPV N and P proteins are able to form LLPS, with P as an important driver. 
In addition, P forms direct associations with RNA (Boggs, unpublished data). To 
carry out these in vitro phase separation assays, our group has developed 
protocols for the effective purification of HMPV viral proteins including HMPV M 
purification, which is currently being optimized. Future studies will focus on the 
effects of HMPV M on the formation of these LLPS structures. In addition, testing 
whether HMPV M, like HMPV P, can directly modulate RNA binding would 
enhance our understanding of the roles of HMPV M in viral replication and 
transcription. 
Calcium binding in the functions of HMPV M 
Leyrat et al. published in 2014 that HMPV M is a calcium binding protein. 
[83]. In Chapter 4, we investigated the role of calcium binding residues in the 
expression and folding of HMPV M. We found that single and combination alanine 
mutations to the HMPV M calcium-coordinating did not affect expression. 
However, we observed loss of conformational antibody binding with alanine 
mutants of residues that directly coordinate calcium binding. These studies 
suggest that HMPV M calcium binding is essential for proper folding of the protein; 
however, our studies are limited as we have not directly shown that these 
mutations result in lack of calcium binding. Further studies using purified M or M 
mutants could be utilized to verify loss of calcium binding, including and 
crystallization of HMPV M mutants would verify whether the changes we observed 
result from lack of calcium binding. 
 Additionally, it would be important to determine the effects of calcium 




recombinant virus with M mutants. Since M is heavily involved in budding and 
assembly of nascent viral particles, the potential challenge to overcome lies in 
whether improperly folded M would yield enough viral titer for subsequent 
experiments. In the situation that the recombinant HMPV M cannot be rescued, I 
propose transcomplementation of HMPV M either using transient transfection of 
plasmid-encoded wild type M, or with a stable cell line that expresses wild type M 
for the recombinant calcium-binding-mutant HMPV M viral growth. A similar 
strategy was employed for the closely related RSV virus, where M was completely 
removed from the genome [216]. Using these recombinant viruses, the effect of 
the mutations to the calcium binding residues on nuclear localization, membrane 
association, replication, transcription, and inclusion body dynamics could be 
studied. In addition, immunoprecipitation coupled with mass spectrometry of 
calcium-binding mutants compared to wild type could establish potential host 
interactions mediated through calcium binding. 
 Altogether, the work discussed in this dissertation contribute to our 
understanding of NNS RNA  viral infection. Continuing research in the field, 
including the outlined future directions would serve to create a framework for 
identifying factors that in the long term may serve as effective therapeutic targets. 





Sequences used in the design of M-specific PPMO 
ACCESSION #     SEQUENCE 
MF104608.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
MK588635.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KJ627433.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KJ627407.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KJ627427.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KJ627425.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KJ627394.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KY474534.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
AB503857.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KC403981.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
MH150889.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KC403979.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KF686742.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
AY297749.1      GGGACAAGTGAAAATGGAGTCCTAT 25 
KY474537.1      GGGACAAGTAAGAATGGAGTCCTAT 25 
GQ153651.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MN745084.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MK087726.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MN745087.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MK167039.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KY474539.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MF104609.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MK167040.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MN306028.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MN745085.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MF104602.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MF104594.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MF104610.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KC562233.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
AY530090.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
AY530095.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KC562221.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KC562240.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KJ627417.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KJ627379.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KJ627422.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KJ627430.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KJ627406.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KC403978.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KC403984.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
KC562243.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
MF104611.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
JN184400.1      GGGACAAGTAAAAATGGAGTCCTAT 25 
DQ843659.1      GGGACAAATAAAAATGGAGTCCTAT 25 










List of abbreviations 
6HB six-helix bundle 
ANP32B acidic leucine-rich nuclear phosphoprotein 32 family member B 
BDV Borna disease virus 
CD cluster of differentiation  
CDV canine distemper virus 
ChIP chromatin immunoprecipitation 
CPE cytopathic effects  
CRM1 chromosomal maintenance 1 (exportin 1) 
CT cytoplasmic tail 
CTD C-terminal domain 
EBOV Ebola virus 
ER endoplasmic reticulum 
F fusion protein 
FISH fluorescence in situ hybridization  
FP fusion peptide 
G/GP  glycoprotein 
G/GP/H/HN attachment protein 
GPI glycosylphosphatidylinositol 
H/HA hemagglutinin 
HeV Hendra virus 
HMPV  human metapneumovirus 
HN hemagglutinin/neuraminidase 
hpi hours post infection 
hPIV human parainfluenza virus 
HRA/B heptad repeat A/B 
IAV influenza A virus 
IB inclusion body 
IBV influenza B virus 
ICAM intercellular adhesion molecule  
IP immunoprecipitation 
JPV J paramyxovirus  
L large protein 
LIZ leucine/isoleucine zipper 
LLPS liquid-liquid phase separation  
M matrix protein 
M2-1 matrix 2-1 protein 
MDA5 melanoma differentiation-associated protein 5 
MeV measles virus 
MOI multiplicity of infection 
MPER membrane proximal external region  
MS mass spectrometry 





NDV Newcastle disease virus 
NES nuclear export signal 
NiV Nipah virus 
NNS non-segmented negative sense  
NPC nuclear pore complex 
Npm nucleophosmin 
NS non structural protein 
NTD N-terminal domain 
P phosphoprotein 
PIV5 parainfluenza virus 5 
poly (I:C) polyinosinic:polycytidylic acid 
PPMO peptide-conjugated phosphorodiamidate Morpholino oligomer 
PS phosphatidylserine 
RdRp RNA dependent RNA polymerase 
RIG-I retinoic acid-inducible gene I 
RNP ribonucleoprotein 
RSV respiratory syncytial virus 
RV rabies virus 
SE-AUC sedimentation equilibrium analytical ultracentrifugation  
SeV Sendai virus 
SH small hydrophobic protein  
SLAM signalling lymphocyte-activation molecule 
TGN trans Golgi network 
TLR 3 Toll-like receptor 3 
TMD transmembrane domain 
TNF-α tumor necrosis factor alpha 
TRV Tupaia rhabdovirus 
UBF upstream binding factor F 
UTR untranslated region 
VLP virus-like particle 
VP24 viral protein 24 
VP40 viral protein 40 
vRNA viral genomic RNA 
VSV vesicular stomatitis virus 
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FELLOWSHIPS & FUNDING 
College of Medicine Fellowship for Graduate Research   August 2017-August 2018 
Lyman T. Johnson Fellowship                                                   August 2016-Present 
 
 
HONORS AND AWARDS 
Emerging Scholar, Faculty of Color Network 
Selected by the Faculty of Color Network at the University of Kentucky based on 
work in diversity and inclusion, academic achievement, and research excellence. 
 
Pillar Award for Belonging and Engagement 
Awarded by the Graduate Student Congress at the University of Kentucky for work 
in planning, advocacy, and fundraising for highlighting and celebrating diversity on 
campus. 
 
Lloyd E. Alexander Memorial Award 
Selected by the Biology faculty at Kentucky State University—based on academic 
performance, research, leadership qualities and service to the unit and peers. 
 
President’s Senior Award 
Awarded to seniors with the highest cumulative grade point average at Kentucky 
State University. 
 
Dean’s Outstanding Student in Mathematics and Science Award 
Awarded for excellence in Mathematics and Science at Kentucky State University. 
 
Outstanding Biology Student Award 
Awarded for excellence in major or study at Kentucky State University. 
